Podcasts about global health equity

2025 Harvard Horizons Scholar Katherine Venturo-Conerly is on a mission to revolutionize access to effective mental health care—particularly for young people. Her research project, "Tackling the Global Youth Mental Health Challenge: Lessons from Psychotherapy Research in Kenya," focuses on creating and implementing effective, accessible mental health interventions for children and adolescents in multiple countries, with a particular focus on Kenya. As co-founder of Kenya's Shamiri Institute with her Harvard College classmate Tom Osborn, Venturo-Conerly is developing a collaborative and sustainable approach to bridge the mental health care gap around the world. In this talk delivered in April 2025 at the annual Harvard Horizons Symposium, Venturo-Conerly talks about creating, testing, and implementing effective, accessible mental health interventions for children and adolescents across multiple contexts.

On Episode 565 of Impact Boom, Manny Ohonme of World Shoe Inc. discusses how receiving a single pair of shoes as a child sparked a global movement, the role of visionary leadership in catalysing sustainable impact, and how purpose-driven manufacturing in African is advancing health, dignity, and community empowerment. If you are a changemaker wanting to learn actionable steps to grow your organisations or level up your impact, don't miss out on this episode! If you enjoyed this episode, then check out Episode 192 with Bete Demeke on the five essential components for rural community development -> https://bit.ly/4d24XSV The team who made this episode happen were: Host: Indio Myles Guest(s): Manny Ohonme Producer: Indio Myles We invite you to join our community on Facebook, Twitter, LinkedIn or Instagram to stay up to date on the latest social innovation news and resources to help you turn ideas into impact. You'll also find us on all the major podcast streaming platforms, where you can also leave a review and provide feedback.

Welcome to our new mini-series on research capacity strengthening, produced in partnership with the Centre for Capacity Research at the Liverpool School of Tropical Medicine. In this first episode, we explore the design of a Research Capacity Strengthening (RCS) component within an implementation research project, and why it is crucial for sustainable, patient-centred healthcare. Our conversation draws insights from those actively embedding RCS into their work, demonstrating how improving research skills and systems drives real impact in global health.In this episode:Dr. Justin Pulford - Reader at the Centre for Capacity Research, Liverpool School of Tropical Medicine.Dr. Justin Pulford is Deputy Head of the Centre for Capacity Research (CCR) at the Liverpool School of Tropical Medicine (LSTM). A behavioural scientist by training, he has extensive experience developing, implementing, and evaluating research and health systems strengthening initiatives across sub-Saharan Africa and the South Pacific. Dr Pulford also convenes the ‘TROP 703: Public Health Programmes, Policies and Strategies' module for LSTM's MPH programme. Professor Obiageli Nnodu - Co-lead of the PACTS programme, University of Abuja.Professor Obiageli Nnodu is Professor of Haematology and Blood Transfusion at the University of Abuja, Nigeria, and Director of its Centre of Excellence for Sickle Cell Disease Research and Training. She leads multiple NIH-funded sickle cell projects and chairs Africa's largest SCD network. Professor Nnodu also advises the Nigerian government on non-communicable diseases and serves on WHO AFRO committees dedicated to improving sickle cell care.Professor Alex Osei-Akoto - Kwame Nkrumah University of Science and Technology, GhanaProfessor Alex Osei-Akoto is Principal Investigator for PACTS in Ghana. A Professor of Child Health at Kwame Nkrumah University of Science and Technology (KNUST) and Consultant Paediatrician at Komfo Anokye Teaching Hospital, he has focused on sickle cell disease for over two decades. Professor Osei-Akoto led key newborn screening initiatives, advised Ghana's Ministry of Health on SCD, and co-authored numerous publications. He now spearheads PACTS implementation in Ghana, building on his extensive clinical and research leadership in paediatric haematology.Dr. Catherine Chunda-Liyoka - University of ZambiaDr. Catherine Chunda-Liyoka is Head of the Paediatric Haematology Department at Zambia's University Teaching Hospitals–Children's Hospital. She provides specialised care in sickle cell disease, haemophilia, aplastic anaemia, HIV, and TB, while leading multiple research initiatives. As an Honorary Lecturer at the University of Zambia and an Honorary Fellow at LSTM, she mentors health workers nationwide. Dr. Chunda-Liyoka also advises the Zambian Ministry of Health on paediatric haematology and infectious diseases, and plays a key role in major SCD networks—including SPARCO and PACTS—to strengthen national guidelines and clinical practices.Useful linksCentre for Capacity Research | LSTMPatient-centred sickle cell disease management in sub-Saharan Africa (PACTS) | LSTMWant to hear more podcasts like this?Follow Connecting Citizens to Science on your usual podcast platform or YouTube to hear more about current research and debates within global health.The podcast cuts across disciplines, including health systems strengthening, gender and intersectionality, tropical diseases (NTDs, TB, Malaria), maternal and child healthcare (antenatal and postnatal care), mental...

Shaneeta Johnson, MD, is an Associate Professor of Surgery, Director of Minimally Invasive, Robotic, and Bariatric Surgery, and Program Director, General Surgery Residency Program at Morehouse School of Medicine and Grady Hospital in Atlanta, Georgia. She is also a Senior Fellow of Global Health Equity in the Satcher Health Leadership Institute. She is an experienced surgeon, clinician, educator, philanthropist, and researcher. Shaneeta received her education and surgical training at Johns Hopkins University, Loma Linda University School of Medicine, Howard University Hospital, The Cleveland Clinic and Brandeis. She is a Fellow of the American College of Surgeons, the American Society of Metabolic and Bariatric Surgeons, and the International College of Surgeons. She is board certified in both General Surgery and Obesity Medicine. She has been appointed to leadership positions within state, national, and international organizations and committees.Shaneeta is passionate about furthering health equity and eliminating disparities. She has been involved and/or spearheaded national and international initiatives to improve health equity. She is a sought-after speaker whose expertise has afforded her invitations to speak both nationally and internationally. She is a recipient of the NMA Emerging Leader Trailblazer Award, American College of Surgeons Claude Organ Traveling Fellowship, Atlanta Business Chronicle 40 under 40 award, 2020 Women who Mean Business Award, and the 2019 Outstanding Atlanta award. In her spare time, she enjoys spending time with family, traveling, running, and water sports.

Global health systems are built on power structures that often exclude the very voices that should be leading the conversation. Funding, publishing, and policymaking have long been dominated by high-income countries, creating systemic barriers to equity.In this episode, Dr. Shashika Bandara (McGill School of Population and Global Health), Dr. Moses Tetui (Umeå University & University of Waterloo), and Dr. Joseph Mumba Zulu (University of Zambia) discuss two major initiatives that challenge these structures:The Lancet article: Shifting Power in Global Health Will Require Leadership by the Global South and Allyship by the Global North and The launch of the Journal of Community Systems for Health, a new platform breaking barriers in global publishing and knowledge sharing.In this episode:Dr. Shashika Bandara - Post-Doctoral Fellow, Department of Global and Public Health, School of Population and Global Health, McGill University.Shashika Bandara is a Sri Lankan post-doctoral fellow at the Department of Global Public Health in the School of Population and Global Health at McGill University. He co-leads McGill University's research examining policy exemplars successfully addressing structural discrimination with O'Neill-Lancet Commission on Racism, Structural Discrimination and Global Health. Dr. Joseph Mumba Zulu - Associate Professor of Community, School of Public Health, University of Zambia Joseph M Zulu is a co-founder and Editorial Board Member of the Journal of Community Systems for Health, a platform dedicated to promoting inclusive, socially accountable, and community-driven health systems research. He is an Associate Professor of Community Health at the School of Public Health and has been involved in community-based implementation research projects in different countries across Africa.Dr. Moses Tetui - Assistant professor, University of Waterloo, Canada and Umeå University, SwedenDr. Moses Tetui is a Health Systems Researcher who specialises in using participatory methods to collaborate with diverse communities and stakeholders to address health system challenges. He serves as a founding board member of the Journal of Community Systems for Health. Moses collaborates with researchers, communities, and decision-makers to explore climate change adaptation strategies for communities living in informal settlements across Africa. Useful links:How to prevent equity efforts from losing steam in global health academiaImagining a future in global health without visa and passport inequitiesShifting power in global health will require leadership by the Global South and allyship by the Global NorthThe Journal of Community Systems for Health (JCSH)Want to hear more podcasts like this?Follow Connecting Citizens to Science on your usual podcast platform or YouTube to hear more about current research and debates within global health.The podcast cuts across disciplines, including health systems strengthening, gender and intersectionality, tropical diseases (NTDs, TB, Malaria), maternal and child healthcare (antenatal and postnatal care), mental health and wellbeing, vector-borne diseases, climate change and co-production approaches. If you would like your project or programme to feature in an episode or miniseries, get in touch with the producers of Connecting Citizens to Science,

Craig Spencer is an emergency medicine physician and an associate professor of the practice of health services, policy, and practice at the Brown University School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. C. Spencer. Ebola and a Decade of Disparities — Forging a Future for Global Health Equity. N Engl J Med 2025;392:313-315.

Dr. Anne Marie Amies Oelschlager is a Professor of Obstetrics and Gynecology and Adjunct Professor of Pediatrics at the University of Washington School of Medicine. She founded, developed, and expanded the Pediatric and Adolescent Gynecology Division at the University of Washington to provide care to patients across the Pacific Northwest, including Alaska, Idaho, Montana, and Oregon. Her clinical expertise is in contraception and hormone therapy, pubertal and menstrual disorders, congenital anomalies of reproductive organs, differences of sex development (intersex conditions), and reproductive health issues complicated by underlying physical or developmental disability or underlying medical conditions.  She also serves as Chair of the American College of Obstetricians and Gynecologists Clinical Consensus Gynecology Committee. She is a clinical instructor and lecturer on reproductive health care for the medical students at the University of Global Health Equity in Rwanda. Links mentioned: bedsider.org

Title: Association of Neighborhood Opportunity With Pediatric Day of Surgery Cancellations Dr. Brittany Willer discusses her paper, “Association of Neighborhood Opportunity, Race, and Ethnicity with Pediatric Day-of-surgery Cancellations,” that was recently published in Anesthesiology. The full text of her paper can be found at the following link: https://pubmed.ncbi.nlm.nih.gov/38787688/

For much of history, the word 'epidemic' applied to infectious diseases. Large numbers of cases of disease caused by organisms such as bacteria and viruses that spread through water, air, or other means, sometimes transmitted from person to person, or back and forth between people and animals. Then came epidemics of chronic diseases such as obesity, diabetes, heart disease - diseases occurring in very large numbers and created not by infectious agents, but by drivers in our day to day lives, such as a bad food environment. A new paper was just published in the PLOS global health literature that I found fascinating. It focuses on another use of the concept of epidemics: market driven epidemics. Let's find out what these are and find out a little bit more about their implications for our health and wellbeing. Our guests today are two of the authors of that paper. Dr. Jonathan Quick is a physician and expert on global health and epidemics. He is an adjunct professor at Duke University's Global Health Institute. Eszter Rimanyi joins us as well. She works on chronic disease and addiction epidemiology at Duke university. Interview Summary Access the PLOS article “Dynamics of combatting market-driven epidemics: Insights from U.S. reduction of cigarette, sugar, and prescription opioid consumption.” So, Jono, let's start with you. Tell us what you mean by market driven epidemics. The pattern is familiar to people. There is a product that that humans like and the business community says we can make a lot of money on this unmet need. And so they do that and they start selling a lot of it. And then people start noticing that this thing that the humans like is killing some of them. And so, the scientists do the public health. And then the business community says these scientists are going to kill the golden goose. They buy up other scientists and try to defend themselves. And then it goes on and on before we really bend the epidemic curves. This pattern of consumer products that have harmful effects, those products are major contributors to the root causes of at least a million deaths a year in the US, and over 20 million deaths worldwide. So, to try to look at this from an epidemic point of view, we first established a case definition. Our definition of market driven epidemic is a significant increase in death, disability and other harmful effects on humans and human health and wellbeing. It's arising from a consumer product whose use has been accelerated by aggressive marketing. Whose harmful effects have been denied or otherwise minimized by producers. And for which effective mitigation is possible but actively opposed by producers. So, we looked at the natural history of this, and we found five phases through which these epidemics pass. There's market development, either inventing a new product, developing a product like prescription opioids, or transforming an existing product like tobacco. Phase two is evidence of harm. First, there's suspicion, astute clinicians, whistleblowers, and then eventually proof of harm. Phase three is corporate resistance. Companies deny harm, seek to discredit accusers, commission counter science, manufacture doubt, mount legal challenges. All the while deaths and social upheaval and economic costs are mounting. And finally, our next phase four is mitigation. We get some regulatory efforts going, and there's a tipping point for the consumption and resulting deaths. And then finally, phase five of this is market adaptation. In a response to decreasing or threatened consumption, companies and consumers typically seek alternatives. Adaptations can be positive or negative. Some are healthier, some are equally or more harmful. Thanks very much for that description. It really helps explain what the concept is all about. You chose three areas of focus. You could have chosen others, but you chose cigarettes, sugar, and prescription opioid use. Why those in particular? We wanted to identify differences in these market driven epidemics in a few product categories. We wanted to look at distinctly different consumer experiences so we could see what worked and what didn't in terms of bending the epidemic curve. We picked nicotine delivery, food, and prescription medicine. And to choose within those categories we established five inclusion criteria. So, number one, the product had to have proven adverse health effects. Number two, there needed to be well documented histories of product development, marketing, mitigation efforts, and so forth. Number three, the product needed to meet the overall case definition. That is, companies knew they were doing harm, continued to do harm, and fought that harm. Number four, there needed to be long term data available for product consumption and associated impact. And number five, most important, we chose products for which mitigation efforts had already resulted in significant sustained reduction in product consumption. Based on these three criteria, cigarettes, sugar, and prescription opioids came out as the ones that we studied. Thanks. I really appreciate that description. And when we get to the punchline in a minute, it's going to be interesting to see whether the behavior of the industry in this natural history that you talked about is similar, given that the substances are so different. We'll get to that in a minute. So Eszter, I'd like to turn to you. What kind of information did you pull together to write this paper? I think I looked at over a thousand different documents. But there were two clear types that I interrogated to pull together all of our background data. The first category was publicly available data, so that could have been a clinical study, epidemiological study, advertisement by the company, CDC or other government reports, mortality data, etc. But then there was also a distinct different type of data that we really looked at and that was really useful for putting together these pictures of the natural history, which was internal documents. In some cases, these could have been leaked by an internal employee, which was the case with the so called 'brown documents' with tobacco. But it also came from sometimes court hearings or as a result of lawsuits that the companies had to release internal data. It was really interesting to compile together the different sides, of the outside look from CDC reports, and then the insider scoop from Purdue Pharma. So, it's a very well rounded, interesting way to find all this data. I admire your effort. It's a big job to do a normal scientific review where you might have 50 papers and you were looking at things that were much harder to obtain and a vast number of things that are really quite different in character. Boy, congratulations for just reading all those things. Tell us what you found. Gosh, so even though there's so many distinct differences between a lot of these epidemics, what we actually found was that there was a lot of narrative similarities. And because of that, we could really create this holistic, but also really well-fitting idea of market driven epidemics. A lot of the corporate strategies were either mirrored, imitated, or in some cases quite literally lifted over because of overlapping ownership between the companies. One of the things that we really wanted to hammer into our article was that producers not only created their product, but they also manufactured doubt. Which means that they created, on purpose, public hesitancy around their product even when they internally knew that it was harmful to health. They wanted the public to be on the fence about what the health impact of their product was. There was a lot of different ways that they achieved that goal. Sometimes it was through showing propaganda films in high schools. Which I still can't believe that happened and then that was legal. But also in different ways, like co-opting science, paying scientists to publish articles in their favor. I know a really famous example of this that has now been public is that two Harvard researchers in cardiovascular disease published saying that sugar was not harmful to health. So, there's a lot of different ways that they achieved it, but the goals overall were very similar by all the companies. You know, you mentioned overlapping ownership. And so, you might have been referring specifically to the ownership of the food companies by the tobacco companies. Correct. Because it happened a while ago, that's not something that was well known. But there's a fascinating history there about how the tobacco industry used its technology to maximize addiction and used that to develop food products and to change the DNA of the food companies in ways that still exist today, even though that ownership ended many years ago. I'm really glad you pointed that out. Yeah, exactly. I think there's this shared idea that there's a turning point for companies. Where they know internally that their product is causing harm. And what really tips them over into becoming market driven epidemics is not actually coming out and saying that there's an issue with their product or not improving it. But you know really digging that information into the dirt and saying no we're going to protect our product and keep giving this out to the public despite the harms. You know, maybe we can come back to this, but the fact that you're finding similarities between these areas suggests that there are contingencies that act on corporate executives that are similar no matter what they're selling. And that's helpful to know because in the future, you can predict what these companies will be doing because there are many more similarities than differences. Jono let me ask you this. You've talked about this appalling period of time between when there are known health consequences of use of some of these things and the time when meaningful action occurs to curb their consumption and to rein in the behavior of the companies. How long is this gap, and what explains it? Kelly, this is one of the most fascinating things about this study. And it really highlights the importance of taking an epidemiologic approach. This is a behavioral epidemic, not a viral one. But it has so many characteristics. One of the key points is that is how important time is. And we see that in any epidemic curve when things start going exponential. If we take cigarettes, okay, the harms of cigarettes had long been suspected. But the first credible scientific publication was by a US physician, Isaac Adler, in a 400-page 1912 book where he first associated cigarettes with cancers. Fast forward over 40 years to British scientists Doll and Hill, and they did the epidemiology which definitively and convincingly links cigarette cancer with smoking deaths. So that gap was incredible and so that's one of the first examples. Once those articles were published, others followed the initial one. It took about a decade until the 1964 Surgeon General's report on smoking and health. And that was quickly followed by a series of federal actions. So, 1964, '63, '64 was the tipping point. Five decades after the initial suspicion. For sugar, the journey from suspicion to compelling evidence was more complex. There was a big debate between researchers, clinicians, scientific journalists, that began in the '50s. A diabetologist from Britain John Yudkin, argued in the 1957 Lancet piece, it's sugar that's equal or larger than fats. An American physiologist, Enzo Keyes, says au contraire. He said it on the cover of Time Magazine. From 1950 to 2000, there was this debate back and forth. Finally, sugar consumption in the US peaked in '99 when a sugar wary group of researchers, journalists, and advocacy groups began becoming really vocal. And that was the tipping point. The actual compelling science, it came a few years after the preponderance of folks engaged said, no, it's sugar. You got to do something. And finally, with prescription opioids: 1997, rural doctors Art Van Zee and another fellow, alerted Purdue Pharma, the producer of OxyContin, about rising overdoses. A year later, there was a publication that said the sustained release version of OxyContin, which was a hydrocodone that was sustained release, that they first tried it with morphine, and they had evidence from there that the sustained release drugs were a problem. And again, it was over a decade later that mounting prescription opioid deaths in the US convinced CDC to declare an epidemic of [00:14:00] opioid prescribing. This gap, if you look at it, to summarize, for cigarettes, the journey from credible suspicion of harm to consumption tipping point, five decades. Sugar, four decades. Prescription opioids, fourteen years. But the key thing is that the power of collective action, because today, only one in eight Americans smoke, and it was nearly 50 percent at the peak. The US consumption of sugar, which increased by 30 pounds between the year 1950 and the year 2000, when all this debate was going on. We picked up an extra 30 pounds of sugar consumption per person per year, but within two decades, that was cut back. We gave back 15 pounds of that. And now prescription opioids have gone back to a medically defendable level, having risen to 8 to 10 times that in the peak of the prescription opioid epidemic. Hearing you talk about that, it's nice that there's sometimes light at the end of the tunnel. But boy, it's a long tunnel. And that you can count the, the number of deaths during that tunnel period of time in the millions. It's just unspeakable how much damage, preventable damage gets caused. Now, and I'd like to, when I come back to wind up this podcast, I'd like to ask each of you, what do you think might be done to help narrow that or shrink that time gap and to prevent these long delays and to help address these corporate determinants of health. But before I get there, Eszter, you know, I'd like to follow up on the conversation we had earlier. You know where it's clear that sugar and tobacco and opioids are all quite different substances, but the companies, the natural history of these things looks quite similar. And you mentioned in particular the industry attempt to plant doubt. To create doubt in the minds of people about the stories they were hearing of the dangers of these things, whether they were true or not. And were there other things that the industry was doing during that time that you noticed might have similarities across these areas? Oh my gosh, so many. I have to go through all the examples in my head and make sure that I have a very crisp message out of all of them One of the ones that is interestingly being employed today in a very different epidemic with firearms and guns, is this idea of whose choice is the consumer product in its use. And today there's a lot of ideas that were initially created by tobacco, and then used by food, that are currently being used by gun lobbyists talking about individual freedoms. So with some of the previous market driven epidemics, like tobacco and prescription opioids, it's a way easier argument to make that the individual at some level does not choose to use the product. Maybe in the beginning, the first couple uses were their individual choice, but then there's on purpose, a really strong withdrawal response in the body and socially. The individual kind of had to continue using the product. But some of those ideas are being used today with firearms. The idea that somebody has the liberty to use this product or to purchase this product, which undoubtedly causes harm. You know, it's probably not really good for public health if this argument exists. And, in the cases with firearms, which I think is a little bit ironic and sad, a lot of the people that buy guns for their own self-defense actually experience those guns turned around and used on them, usually by the perpetrators of aggression. These ideas of individual freedoms usually backfire to the people that are consuming the products. It's interesting to me that a lot of these ideas were initially created for very different products, but are being used in the current day. So interesting to hear you say that because here we have yet another area where there are similarities with the firearms. And the companion argument to that idea that it's your personal liberty to use these things is the argument that there's overreach by government, big brother, things like that. When government wants to, you know. Yeah. It's so interesting. So one point on that. The market economy was never meant to be a free for all. Because the reality is that the market economy has brought billions of people out of poverty and saved more lives than most health interventions. But the problem is, as I said, it wasn't meant to be a free for all. And it depends on having good consumer information and when companies are distorting it, they're basically taking away the informed choice, which is critical. The other part of it is, when they are purposely engineering their products for maximal addictiveness, which is done with clicks and social media, and was done purposefully with the nicotine content in cigarettes, then you don't have a real informed choice. The freedom of choice. You've had your brain pleasure center hijacked by, by purposely addictive products. Right, and you didn't mention food, but there's another example of substances that are created to hijack the reward pathway in the brain. Absolutely. I'd like to ask each of you, what in the heck can we do about this? I mean, you've pointed out a massive problem. Where the number of lives that are sacrificed because of corporate behavior, just enormous numbers. What can we do about it? Jono, I will start with you. And, you know, you've written this very highly regarded book called The End of Epidemics. And you've talked about things like bending epidemic curves and accelerating shifts. But tell us more. What do you think can be done in the case of these market driven epidemics like we're talking about? Well, I think it's important to realize that both kinds of epidemics, viral and behavioral, are communicable. Both involve a lot of rumor, blame, uncertainty. And as we've talked about both cause deaths in the thousands or millions. And we haven't talked so much about the significant social disruption, and the cost. Trillions of dollars in economic losses and additional health burdens. So let me focus on four kinds of key actors because when it comes down to it, it's groups that that really start acting against these things. The first is the research community and its funders. You won't be surprised given the time it takes to get the evidence because what's clear is without clear evidence of product associated harm, we're not going to move the political agendas. We're not going to get public support for epidemic curves. So, we have really good researchers working in these areas. They need to guard against groupthink. That's what happened with our salt sugar 50 years of chaos discussion. And conflict of interest because companies do try to undermine the database. The second is the funders of research, foundations and all, and national health services need to have an early warning system and an annual research roadmap in this area. I think Eszter will probably talk about the importance of public health leaders, because she's looked a lot at that. Another community though is the different civil society groups that are active. Because there's Mothers Against Drunk Driving, there's the Sandy Hook group on gun shooting, and there are a variety of interest groups. But what we realize is that there are lots of different strategies for how you move decision makers and all. So, more information sharing from those groups, civil society groups and all across. And finally, companies. It's actually in their interest to be more forthcoming earlier on. With tobacco, with prescription opioids, and now with baby powder, with talc, what we're seeing is companies at risk of bankruptcy paying billions of dollars. And if their CEOs aren't looking at that, then their board needs to be. Can I ask you a quick question about that? When the chickens come home to roost, and those bad things befall a company, you know, really seriously damaging lawsuits, or the possibility that perhaps sometime the executives will go to jail for corporate malfeasance. You know, the behavior that caused all the millions of deaths occurred 15 CEOs before them. So, if you're a CEO and you know you have a certain shelf life as CEO, you want to maximize profit during that time. And by the time anything happens negatively to the company, you're on vacation, you're retired, or you're gone. So how do you deal with that? Here's the thing, it's having criminal and civil liability that can go back to the individuals involved. From a different sector, an example. The German executive who was head of Volkswagen over a decade ago when they cheated on their environmental issues. He's been criminally charged today, a decade later. And I think that sort of personal accountability, it'll be hard to get, but that's the kind of thing that will make CEOs and their boards, if their boards also become responsible for hiding information in a way that it resulted in deaths. I think that, unfortunately, that kind of hammer, although it's going to be hard to get, that's probably what's needed. Okay, that makes good sense to me, and I'm glad I asked you that question. And I appreciate the answer. Eszter, anything you'd like to add to what Jono said about what could be done. Yes. One of the amazing things about market driven epidemics was when we were creating the paper, we created a table of all the different types of actors that could have very successful mitigation. And that table actually ended up being cut from the paper because it was so long that the editor said that it might distract from the rest of the paper. But that's actually a very positive message because there are so many actors that can have positive change, I'm going to highlight a couple of them because I think there's a few things here that are fairly good core messages that we can take away. One of the ones is the need for a trusted public health authoritative voice. I think nowadays there's a lot of commotion over how much we trust the government. And how much we trust, for example, the head of the CDC and the types of data they're talking about in terms of public health. But in the past, when we had a very trusted public health voice, that was really crucial in getting consumers to change their behavior. For example, in the 1964 Surgeon General's report, seemingly overnight changed people's behavior. Before then, smoking was a common, everyday social event. And after that, people started viewing it as a deadly, bad habit that some people had. And that type of change was really hard to get in the modern day. When we were talking about public health crises that were viral. So, I think one of the things that we really need to get again in the modern day is this trust between the people and public health voices so that when we have such good forthcoming information those statements actually mean something. So much so that the consumers change their behavior. Another thing is with us individuals who maybe aren't part of public health, we actually play a pretty big role in how much other people consume these different products. I remember when I was researching cigarettes in particular and the intersection with social media. I think if somebody under 18 saw a peer smoking and posted that to Instagram, that doubled their likelihood of trying out smoking for the first time. You have to be really careful with how you show yourself in the presence of others, and online too with a new digital age. Because you might tip the scale in somebody trying out a product for the first time. Which then if it has a very strong withdrawal effect, you know that person might have to might feel that they have to continue using that product to avoid withdrawal. I think as an individual, you can be more mindful about if you have a certain product use that you don't want others to also pick up, to maybe not do it or not show it as much so that other people aren't interested in doing that. Okay, the last really positive message I have is that I think as my generation gets into higher positions of power, even within corporations, I think Gen Z and Gen Alpha and other young people have the sense of responsibility for others and for the planet. And I think if there was a young person in power in a corporation and saw that oh no this product that we've had is now there's evidence that's harmful. I think there would be more accountability and more of a want to do something that's good for the planet and for people. I'm hopeful that, maybe 50, 60 years ago, if people were more in favor of kind of brushing things under the rug, then maybe the young generation won't be as into those ideas. And we'll actually want to be accountable and do what's right. BIOS Jonathan D. Quick, MD, MPH (“Jono”) is adjunct Professor of Global Health at the Duke Global Health Institute, where he teaches global health policy, serves on foundation grant advisory boards, and mentors students. Dr. Quick's current research and writing focuses on market-driven epidemics, from tobacco to opioids to social media.  He is also Affiliated Faculty in Global Health Equity, Brigham and Women's Hospital/Global Health & Social Medicine, Harvard Medical School. Dr. Quick is the author of The End of Epidemics: The Looming Threat to Humanity and How to Stop It  (Australian, Italian, Korean, South Asia, U.K. and U.S. 2018/2020/2021 editions), creator of MDS-3: Managing Access to Medicines and Health Technologies and an author of  The Financial Times Guide to Executive Health, Preventive Stress Management in Organizations, as well as more than 100 other books, chapters, and articles in leading medical journals.  Eszter Rimanyi is a chronic disease epidemiologist working with Dr. Jonathan D. Quick at the Duke Global Health Institute. Her research interest centers around Market-Driven Epidemics, including tobacco, sugar, opioids, and breastmilk substitute/infant formula. She is currently working on applying the market-driven epidemics approach to new epidemics, such as social media and firearms. Rimanyi has authored scientific papers in journals such as PloS Global Public Health and MDPI.

Ben Plumley sits down with Dr. Benjamin LaBrot to discuss innovation and equity in global health diagnostics, focusing on diagnostics' pivotal role in addressing HIV Disease. The conversation covers key themes in diagnostic integration, barriers in middle-income countries, and the critical role of diagnostics in disease prevention and management for other conditions as well, like hepatitis, and tuberculosis. Host: Ben Plumley, Global Health Strategist Guest: Dr. Benjamin LaBrot, Physician and Global Health Advocate, Roche Diagnostics Key Topics Covered Diagnostics and Patient Empowerment Diagnostics are essential for individual treatment and monitoring, especially for diseases like HIV. LaBrot emphasizes that diagnostics need to evolve to provide integrated testing options for a holistic patient approach. Integration in Global Health Services Dr. LaBrot highlights the need for integrated diagnostic services to reduce fragmentation in healthcare, where separate tests for HIV, STI, hepatitis, and TB are offered. This integration can streamline diagnosis and improve patient care, particularly in low-resource settings. Middle-Income Country Challenges Middle-income countries feel underserved in global health funding and support, often excluded from international resources aimed at lower-income nations. Dr. LaBrot advocates for a more inclusive funding approach, arguing these countries have the infrastructure to maximize benefits from increased diagnostic support. Advances in Diagnostic Technology Dr. LaBrot shares how innovative approaches like plasma data separation cards offer practical solutions for remote and low-resource settings, enabling stable blood sample transport without refrigeration. This innovation bridges the gap between point-of-care testing and lab-based diagnostics, crucial for rural and underserved areas. The Role of Influencers and Education in Health Communication Both Ben Plumley and Dr. LaBrot stress the importance of reaching patients through trusted community influencers and digital platforms. Highlighting Panama's COVID-19 communication strategy, they underscore how trusted leaders and influencers can combat misinformation and promote health education effectively. Memorable Quotes “In a fragmented healthcare system, diagnostics integration is not just optimal; it's essential for the effectiveness of any treatment.” - Dr. Ben LaBrot “Middle-income countries feel left out—too well-off to receive international aid but lacking resources to implement comprehensive healthcare.” - Dr. Ben LaBrot Connect with Us If you enjoyed this episode, please subscribe, rate us five stars, and share the conversation on global health equity. For more updates, follow us on LinkedIn, YouTube, and Spotify. Facebook and Instagram: @ShotArmPodcast Youtube: www.youtube.com/@shotarmpodcast LinkedIn: https://www.linkedin.com/company/shotarmpodcast Spotify: https://open.spotify.com/show/69XpqCLn9oL2yU3votRIlO?si=8c14b13f7b8b48b3 Website: www.ashotinthearmpodcast.com Production Team Produced by Erik Espera (NewsDoc Media)  Assistant Producer: Y-Isha Rafael

Title:  Health Equity Curriculum for Anesthesia Residents OA Global Health Equity Section Editor Sam Percy interviews OA Global Health Equity Associate Section Editor Betelehem Asnake about her background and work creating a health equity curriculum for surgery and anesthesia residents that is freely available online. The link to the resources as well as some of the topics discussed on the podcast are below. UCSF CHESA Health Equity Curriculum - The Health Equity Curriculum (HEC) was created by the Center for Health Equity in Surgery and Anesthesia (CHESA) at the University of California, San Francisco (UCSF) with contributions from multidisciplinary collaborators. The HEC was designed to fill a gap in health equity education for surgery and anesthesia residents to better serve patients. The curriculum is intended to be integrated into the core training for all residents, provide exposure that generates career interest, and be complimented by more robust training opportunities and pathways in global health. https://globalsurgery.org/health-equity-curriculum/ UCLA Anesthesiology Global Health Equity - This mission of the UCLA Anesthesiology Department's Global Health Equity section is, “To be at the forefront of various aspects of global health equity work in anesthesia around the world through education, research and advocacy by working hand in hand with collaborators in low-resource settings.” https://www.uclahealth.org/departments/anes/about-us/justice-equity-diversity-and-inclusion/global-health-equity One Voice - One voice helps Los Angeles families and students struggling against poverty through family, hope and love. https://www.onevoice-la.org/

Send Dr Khan a Text Message. Ask a question or say hi!Dr Rachel Hall-Clifford is a medical anthropologist and a global health expert who has done extensive field work to improve systemic health inequities around the world. When she developed Long Covid after an infection in 2022, those systemic failures became a personal issue. Dr Hall-Clifford wrote a powerful article on her experience with Long Covid and the role wealthy countries play in the global treatment of this disease. In our conversation, she speaks about her personal struggles and the universal need for Long Covid treatment."Long Covid Feels Like a Gun to My Head" https://www.statnews.com/2024/06/18/long-covid-infectious-disease-expert-personal-story-life-with-no-cure/"Underbelly: Childhood Diarrhea and the Hidden Local Realities of Global Health"https://mitpress.mit.edu/9780262547765/underbelly/safe+natalwww.safenatal.org Dr Hall-Clifford's TedX Talk on Co-Design in global public health: https://www.youtube.com/watch?v=rvRAdsQ1_hA Rachel Hall-Clifford (PhD, MPH, MSc) is Associate Professor in the Center for the Study of Human Health and the Department of Sociology at Emory University. She is a medical anthropologist who applies social science approaches to global health research and implementation. Her research areas include accessible health care for marginalized populations, health systems strengthening in post-genocide contexts, and global health fieldwork ethics. She is author of the new book, Underbelly, focusing on the multivalent power asymmetries in global health.  Rachel is also Co-Founder of safe+natal, a perinatal monitoring and care toolkit developed with Guatemalan midwives. Global health was brought home in a new way for Rachel since the covid infection that led to long covid in 2022. Follow me on X @doctor_zeest

This UVA Speaks podcast features Scott Heysell, the Thomas H. Hunter, Associate Professor of International Medicine and Director of the Center for Global Health Equity at the University of Virginia. Dr. Heysell is an active clinician and researcher who supports partners worldwide in reducing tuberculosis-related deaths. He describes the work of UVA's Center for Global Health Equity, which offers interdisciplinary research and clinical training opportunities across various global locations like Rwanda, South Africa, India, Nicaragua, and Southwest Virginia. In collaboration with their international partners, Heysell and the Center's clinicians and researchers seek to dismantle structures of inequity and marginalization, respond to community needs, and build more equitable and effective global healthcare systems. Transcripts of the audio broadcast can be found here. Scott Heysell, MD, MPH, is the Thomas H. Hunter Associate Professor of International Medicine and Director of the Center for Global Health Equity at UVA Health at the University of Virginia. Dr. Heysell is an active researcher and supports partners worldwide to reduce tuberculosis-related deaths and correct factors that contribute to tuberculosis, including poverty, health system management, and chronic medical conditions such as HIV and diabetes. His research group also studies maximizing drug efficacy to improve treatment outcomes.

Title:  The Price We Pay - The Impact of Changes in Halothane Production on Anesthetic Care Around the World Open Anesthesia Global Health Equity editor Dr. Sam Percy interviews Dr. Mohamed Kargbo and Dr. Eric Vreede, two physician anesthesiologists, about recent changes in halothane manufacturing and the expected global impact on the provision of anesthetic care in low and middle income countries. Both Dr. Kargbo and Dr. Vreede are active in clinical practice in Sierra Leone and Dr. Vreede is a member of the World Federation of Societies of Anesthesiologists Halothane Working Group.

In this insightful conversation, Dr Ricardo Baptista Leite, the CEO of HealthAI and Chair of the Unite Parliamentarians Network for Global Health, shares his remarkable journey and vision for leveraging AI to advance global health equity. From his early passion for public service to his roles in parliament, medical practice, and leading initiatives, Dr Leite discusses the inflection points that shaped his career. He delves into the work of HealthAI, a global agency focused on responsible AI in healthcare, and the Unite network, which unites parliamentarians worldwide to promote science-based policymaking. Dr Leite also highlights the AI for Good Global Initiative, a collaborative effort between the WHO, ITU, and WIPO, emphasizing the importance of an inclusive, global approach to AI regulations and fostering innovation while ensuring no one is left behind. 00:08- About Dr Ricardo Baptista Leite Ricardo has a marvelous background and contribution across many dimensions, particularly in healthcare.  He has worked in Parliament and as a physician as well.  He was part of the COVID emergency and worked in the COVID emergency rooms. --- Support this podcast: https://podcasters.spotify.com/pod/show/tbcy/support

Join hosts Marla Dalton, PE, CAE, and William Schaffner, MD, for an engaging conversation with Seth F. Berkley, MD, a global health pioneer and champion of equitable access to vaccines. He shares insights from his notable career, including his impactful work in Uganda rebuilding the immunization program and developing the national AIDS control program, his work with Gavi, the Vaccine Alliance, and his trailblazing leadership of COVAX, which helped deliver more than 2 billion doses of COVID-19 vaccines globally to 146 countries.Show notesAn infectious disease physician and epidemiologist, Berkley led Gavi for 12 years, raising more than $33 billion and substantially increasing coverage of routine immunization in lower-income countries. He previously founded the International AIDS Vaccine Initiative to develop an AIDS vaccine for developing countries and now serves as a senior advisor for the Pandemic Center at Brown University School of Public Health. Always up for an adventure, Berkley has been featured on the cover of Newsweek magazine, listed by Fortune as one of the World's 50 Greatest Leaders, and has been recognized by TIME as one of the World's Most Influential People. His TED talks have been viewed by more than 2.5 million. In recognition of his work to help protect the most vulnerable populations across the globe, NFID will honor him with the 2024 Jimmy and Rosalynn Carter Humanitarian Award in September2024.

Despite broad awareness and agreement on the need for massive and urgent investment in nursing to transform our complex health and care systems, the American Nurses Foundation's Philanthropic Support for the Nursing Profession report revealed that nursing receives just one penny of every healthcare philanthropy dollar. In this third and final episode in our series of rare, in-depth unscripted conversations with philanthropists, fundraisers, program managers, executive directors, grantees, and innovators we explore the creative, strategic, and evidence-based approaches to investing and fostering nurses as drivers of transformative, systemic change in health systems.   In conversations with Marion Leary, PhD, MPH, RN, Director of Innovation at the University of Pennsylvania's School of Nursing, Howard Reid, Johnson & Johnson Global Head of Global Health Equity, and Ahrin Mishan Executive Director of The Rita and Alex Hillman Foundation, we hear the connection between nurses as catalysts in care delivery transformation and investments in leadership programming and the concern that without addressing the current and significant workplace stresses, the attrition of well trained, skilled nurses from the profession will continue.   Through strategic, targeted, and enduring investments that evolve alongside changing workforce needs, programs like the Hillman Foundation's nurse innovation grants, Design Thinking for Health, Johnson & Johnson's Nursing Innovation Fellowship, and NurseHack4Health demonstrate their powerful impact on career growth, longevity, and preparing nurses in taking on leadership roles within their institutions, in the broader health care sector, and at all levels of public policy. These thought leaders encourage more funders to look at nursing as an investment in accelerating the improvement of our healthcare systems and make clear that nurses are best positioned to identify, implement, and disseminate innovative strategies to advance health care access, quality and equity. Find this episode's resources at www.seeyounowpodcast.com and to find out more information on the podcast bundles visit ANA's Innovation Website at www.nursingworld.org/innovation. Have questions for the SEE YOU NOW team? Feedback? Future episode ideas? Contact us at hello@seeyounowpodcast.com.

Scientific Sense ® by Gill Eapen: Prof. Bruce Ovbiagele, is a professor of neurology and associate dean at UCSF, and chief of staff at the San Francisco Veterans Health Care System. Dr. Ovbiagele's research focuses on reducing the burden of stroke in both the U.S. and Sub-Saharan Africa. --- Send in a voice message: https://podcasters.spotify.com/pod/show/scientificsense/message Support this podcast: https://podcasters.spotify.com/pod/show/scientificsense/support

In this episode we explore John Meade's journey as a passionate public health advocate. An adjunct professor at NYU GPH, John discusses his career trajectory from working in HIV clinics in South Africa to engaging in community health initiatives with the Peace Corps in Peru. John discusses the societal impacts of health, the challenges of HIV stigma, and his ongoing commitment to health equity. Working with AIDS Vaccine Advocacy Coalition (AVAC), he focuses on ensuring the ethical development of HIV prevention medications and advocating for policies that provide access to these vital resources, particularly for underserved communities. Through stories from his work around the world and his current efforts in policy advocacy, John underscores the importance of inclusive health practices and community empowerment. This episode provides valuable insights into systemic health challenges and advancements in HIV prevention and treatment. Join us to hear how John Meade leverages his expertise to effect meaningful change in public health, advocating for equitable healthcare access and strengthening communities through education and informed policy. To learn more about the NYU School of Global Public Health, and how our innovative programs are training the next generation of public health leaders, visit http://www.publichealth.nyu.edu.

In this insightful episode, Dr. Sheridan Langford and Dr. Bethany Hodge, both from the University of Louisville, delve into the transformative journey of global health initiatives in the School of Medicine. They discuss the challenges and opportunities in global health education, the impact of COVID-19 on international programs, and the critical need for equity and decolonization in global health practices. Do you have comments or questions about Faculty Feed? Contact us at FacFeed@louisville.edu. We look forward to hearing from you. --- Send in a voice message: https://podcasters.spotify.com/pod/show/hscfacdev/message

OpenAnesthesia Global Health Equity Section Editor Dr. Sam Percy interviews Dr. Mwemezi Kaino about his experience providing anesthesia services in Tanzania and Kenya and building anesthesia and surgical capacity across the world.
 Dr. Kaino is a consultant anesthesiologist and current chair of critical care medicine at CURE International Children's Hospital in Kenya. He is the former chair of anesthesia and intensive care at Kilamanjaro Christian Medical University.
 Dr. Kaino has decades of experience working in Tanzania and Kenya and shares his stories and wisdom highlighting how perseverance, relationships and ingenuity have shaped his career. 

This installment of The Axis Effect features Shanil Ebrahim, Partner and the National Life Sciences and Healthcare Consulting Leader at Deloitte Canada. As the world's emphasis on healthcare continues to grow, so does the importance of practical innovation, ensuring the best medical care available for all patients. To best deliver the future of medical care requires individuals with a multitude of experiences and education, which is what makes Ebrhaim, who currently holds a position as a joint professor at McMaster University in addition to his job at Deloitte Canada, experience as a researcher at Stanford, and received an MSc in Medical Science and Bioethics as well as a Ph.D. in Clinical Epidemiology, perfect for the job. While the world may often expect individuals with a background like this to become physicians, Ebrahim felt that while working directly with patients was meaningful, he could make a significantly broader impact as a researcher on a “population level.” Ebrahim discusses potential solutions for bringing high-quality healthcare to underserved countries, how different countries undertake innovation policies to advance the world of healthcare, and the role of Artificial Intelligence in healthcare going forward. To learn more, tune in to “Global Health Equity.”

AHIP Executive Vice President Robert Traynham sits down with LaShawn McIver, AHIP's senior vice president and chief health equity officer, for an in-depth discussion about her vision for health equity and her role at AHIP.

Title: What Makes People Sick? One Doctor's Journey Toward Anesthesiology Open Anesthesia Global Health Equity Section editor Sam Percy interviews Dr. Sebastian Mohar Menéndez-Aponte about his career working as a general practitioner in Chiapas, Mexico including the time he spent with Compañeros en Salud (Partner's in Health) and working for the Mexican Ministry of Health and how these experiences ultimately led him to pursue subspecialty training in anesthesiology. You can learn more about the HEAL Initiative fellowship which Dr. Mohar complated by visiting https://healinitiative.org/

Join us for a candid discussion on how vaccines can lead to healthier outcomes for people living with diabetes. Our panelists will discuss the value of vaccines in communities of color, which vaccines are most effective in living well for those with diabetes, and how our community partners and advocacy organizations are a catalyst to promoting the value of vaccination. Moderator Anna Norton, MS President, Center for Sustainable Health Care Quality & Equity, National Minority Quality Forum Anna Norton has worked in the non-profit sector for 25 years as an advocate, fundraiser, speaker, and leader. She has been featured in an assortment of health-related magazines and books, including Balancing Pregnancy with Pre-Existing Diabetes, A Woman's Guide to Diabetes: A Path to Wellness and Diabetic Living. Anna graduated with a Bachelor of Science from the University of Florida and Master of Science in Education at Florida International University. Panelists Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP Endocrinology Clinical Pharmacy Specialist Cleveland Clinic Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP is an Endocrinology Clinical Pharmacy Specialist. She serves as the Co-Director of Endocrine Disorders in Pregnancy and the Director of Education and Training in Diabetes Technology at the Cleveland Clinic Endocrinology and Metabolism Institute. Dr. Isaacs earned her bachelor's degree in chemistry from the University of Illinois at Chicago, Doctor of Pharmacy Degree from Southern Illinois University Edwardsville (SIUE) and completed a pharmacy practice residency at the Philadelphia Veterans Affairs. Dr. Isaacs holds board certifications in pharmacotherapy, ambulatory care, and advanced diabetes management. She served on the American Diabetes Association (ADA) Professional Practice Committee from 2020-2023, the committee that updates the ADA Standards of Care. She is a National Board Member of the Association of Diabetes Care and Education Specialists (ADCES). Tasha Berry-Lewis Health Ministry Director New Spiritual Light Missionary Baptist Church Tasha R. Berry-Lewis is a Health Advocate based in the Chicagoland area. She brings a wealth of experience from her previous role in the federal government, where she specialized in Human Resources, focusing on Labor and Employee Relations, Benefits, Training, and Payroll. Tasha is also a distinguished 20-year military veteran, serving during the Gulf War in Dharan, Saudi Arabia. Since 2021, Tasha has been a part of the National Minority Quality Forum - Faith Health Alliance, where she has been providing educational services to churches in the Chicagoland area on various health-related topics, including influenza, and COVID-19 vaccines. Kristian Hurley Senior Vice President of Programs, Advocacy and Health Equity, Beyond Type 1 Kristian Hurley is the Senior Vice President of Programs, Advocacy, and Health Equity at Beyond Type 1, a global nonprofit that helps people living with diabetes to stay alive and thrive. She is an experienced leader with a history of tripling health impact and revenue by inspiring transformative change in communities through building coalitions to increase health equity. Dr. Enrique Caballero, MD Endocrinologist/Investigator, Division of Endocrinology Diabetes and Hypertension, Division of Global Health Equity, Brigham and Women's Hospital Dr. Caballero is an Endocrinologist, Clinical Investigator and Educator. He is the Faculty Director of International Innovation Programs and Faculty Director of Diabetes Education in the Office for External Education at Harvard Medical School. Dr. Caballero founded the Latino Diabetes Initiative at the Joslin Diabetes Center and the Diabetes Program within the Spanish Clinic at the Brigham and Women's Hospital, both affiliated with Harvard Medical School. He is currently Associate Scientist in the Division of Global Health Equity at the Brigham and Women's Hospital in Boston.

In this compelling episode of The Healthy Project Podcast, I welcome Vanessa Guzman, the dynamic force behind Smartrise Health, a platform meticulously designed to re-engineer and enhance care processes across health systems and organizations. Dive deep with us as we explore the innovative methodologies employed by Smartrise Health in mitigating health disparities and promoting equitable care.Discover insights into: The comprehensive re-calibration and redesign of care processes for health systems and plans, ensure a robust framework to address disparities. The meaningful impact and tangible outcomes of implementing Smart Rise's strategies, including staggering savings and enriched community-focused programs.  Educational platforms and fellowships aimed at empowering healthcare leaders and embedding a culture of health equity across organizations. The benevolent layer of Smartrise, reinvests a significant portion of revenue into charitable activities, thus perpetuating a cycle of giving and community upliftment. Vanessa shares firsthand experiences and innovative approaches towards designing a healthcare model that doesn't just identify, but also strategizes and implements practical solutions for bridging the gaps in quality care. We delve into not just the how but also the why behind creating a healthcare system that is equitable, accessible, and effectively addresses the root causes of disparities.Connect with Vanessa and explore more about Smartrise Health's pivotal role in championing health equity, redefining care processes, and shaping the future of healthcare delivery. www.smartrisehealth.comConnect with Corey:LinkedinInstagramFacebookYouTubeX (formerly Twitter)Website ★ Support this podcast ★

30 Years of Anesthesia Training in Malawi - Part 2 Open Anesthesia Global Health Equity Section Editor, Sam Percy, interviews Cyril Goddia about his career training anesthesia clinical officers in Malawi. This is part one of their two-episode conversation discussing the early days of providing anesthesia care in Malawi, lessons learned from leading an anesthesia training program in Malawi for several decades, and future directions for improving anesthesia safety and access in Malawi. One article discussed during the episode authored by Mr. Goddia is entitled "Surgical and Anaesthetic Capacity of Hospitals in Malawi: Key Insights." The article can be access at the following link: https://academic.oup.com/heapol/article/30/8/985/553107

30 Years of Anesthesia Training in Malawi - Part 1 Open Anesthesia Global Health Equity Section Editor, Sam Percy, interviews Cyril Goddia about his career training anesthesia clinical officers in Malawi. This is part one of their two-episode conversation discussing the early days of providing anesthesia care in Malawi, lessons learned from leading an anesthesia training program in Malawi for several decades, and future directions for improving anesthesia safety and access in Malawi. One article discussed during the episode authored by Mr. Goddia is entitled "Surgical and Anaesthetic Capacity of Hospitals in Malawi: Key Insights." The article can be access at the following link: https://academic.oup.com/heapol/article/30/8/985/553107

Dr. Agnes Binagwaho is a pediatrician, former Minister of Health of Rwanda, Senior Lecturer at Harvard University, Advisor to the Director-General of the WHO, and co-founder of the University of Global Health Equity.  She joins us today to talk about the role of technology in the remarkable transformation of Rwanda's health system post-genocide.  What are the failed promises of health technology? How has data been a North Star to her work? And what does it take to show the world that Rwanda today stands for truth?   Highlights (02m59s) - When health data is held hostage  (04m21s) - HIV is a curse that ushered in the era of electronic medical records (10m06s) - How epidemiological data supports effective health systems governance (16m10s) - Using Twitter to take a stand (20m54s) - Whose data do you trust?   Submit a question or comment to our mailbag, and we'll discuss it on a future show. Emails or voice recordings can be sent to podcast@aidevolved.com  Connect with us on LinkedIn or Twitter (@AidEvolved) and access show notes at https://AidEvolved.com  

An international leader who played a key role in shaping the global COVID-19 vaccine strategy, Katherine L. O'Brien, MD, MPH, is now focused on bringing communities around the world up to date on immunizations and creating an accord to improve the global response to the next pandemic …  

Darrell Castle talks about the World Health Organization's (WHO) proposed treaty which will give it global control over the response to pandemics of every country on earth. Transcription / Notes: PANDEMIC ACCORD- THE TRAIN TO GLOBAL GOVERNMENT Hello, this is Darrell Castle with today's Castle Report. This is Friday the 10th of March in the year of our Lord 2023. I will be talking about The World Health Organization's proposed treaty which will give it control, globally, over the response to pandemics of every country on earth which signs the treaty. This treaty is supposed to promote so called. Global Health Equity which means that in a pandemic or other worldwide disease emergency, Americans should not get better or faster health care from their own government than inhabitants of third-world countries get from the American government. The World Health Organization is a United Nations affiliate formed in 1948. Its website says it does exceptionally beneficial work in mostly third world countries and maybe it does normally. Today, it is demanding that the world's nations surrender sovereignty over the health of their people to this organization which is now more of a World Economic Forum affiliate than a director of world health. The United States has good relations with WHO and even has an ambassador assigned and we will talk about her in a minute. This treaty, which by the way is not a treaty according to the Biden Administration, but an agreement because a treaty must be approved by a two thirds vote of the U.S. Senate to be ratified, but an agreement, according to the administration, can be made binding by executive order. Yes, that's how dishonest, nefarious, and sinister this administration is. Americans will undoubtedly suffer and die needlessly because of this “agreement” but the president intends to enact it by executive order in May of this year. Calling it an agreement instead of an international treaty flies in the face of “our democracy” but nevertheless that is the danger that the American people face. The constitutional requirement to ratify all treaties by a two thirds vote of the senate is bypassed by simply saying it's not a treaty but an agreement. It is a treaty and everybody knows it including the president, but when you have a completely lawless administration other avenues must be taken. America will have surrendered its health sovereignty and will be trapped in a global health prison if this treaty is allowed to be unconstitutionally enacted. Whenever the bureaucrats at the WHO decide to declare a new pandemic no matter how arbitrary and unscientific that decision may be, the American people will be bound by it. The WHO may decide to require massive lockdowns with resulting ruined economies and lives, compulsory masking, social distancing, testing, contact tracing, and of course mandatory injection of killer vaccine poison. The zero draft of the treaty, yes, I call it a treaty because that's what it is, was published this month and it will be finalized in a week or so and then it can be signed by all leaders on earth in a ceremony this May thus laying one more important brick in the wall of global government. The American Revolution is being reversed by the American government right in front of our eyes. The President says he will sign it and then execute it by executive order as soon as it is available thereby giving it legally binding effect over all Americans. If a health emergency is declared by WHO all signatories would have to submit to the authority of the WHO regarding treatments, regulations such as lockdowns and vaccine mandates, global supply chains, and monitoring and surveillance of populations. The WHO gets to decide when to declare an emergency and that body gets to surveil or watch us until it has found one to declare. In conjunction with the World Health Assembly, the rule-making body of the WHO, new pandemic regulations will supersede the laws of member states.

Dr. Elizabeth Drum and Open Anesthesia Editor Dr. Sam Percy discuss Dr. Drum's journey toward a career committed to global health and health equity and the work of the ASA Committee on Global Health. The ASA Committee on Global Health webpage can be found here: https://www.asahq.org/charity Dr. Drum is an Associate Professor in the Department of Anesthesiology and Critical Care at the Children's Hospital of Philadelphia and the current chair of the ASA Committee on Global Health.

“The qualities of a provider that were envisioned fifty years ago are completely different from what the world needs for tomorrow. It's completely different,” insists Dr. Abebe Bekele, who is entrusted with educating this new breed of physician at the University of Global Health Equity in Rwanda. As Bekele explains to host Shiv Gaglani in this special in-person interview on the campus of UGHE in Butaro, Rwanda, COVID-19 has demonstrated that doctors now need to be able to serve as leaders of institutions, manage large projects, raise money and interface with influential public sector players such as policymakers and journalists. The program at UGHE has been designed with that in mind by providing a grounding in liberal arts and humanities along with the necessary medical content. As you'll learn in this insightful conversation, the relatively young school -- which was established by Partners in Health in 2015 -- is taking a thoughtful approach to meeting healthcare needs in the region through admissions policies and scholarships that are boosting the number of female physicians and incentivizing its graduates to practice medicine in their home communities. Beyond connecting with Dr. Bekele, Shiv's visit gave him a chance to meet with students and faculty to gain a deeper understanding of the partnership Osmosis has with UGHE which is part of a larger effort to support medical education in Sub-Saharan Africa, including in Namibia where he was born. As you'll hear, Shiv came away seeing UGHE as a model for health education in an increasingly interconnected world. Mentioned in this episode: https://ughe.org/

Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Barney Graham was a founder of the NIH's Vaccine Research Center, where he served for many years as Deputy Director. He recently became Professor of Microbiology, Biochemistry, and Immunology and Senior Advisor for Global Health Equity at the Morehouse School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin and Others. Audio Interview: What to Expect from Covid-19 Vaccines. N Engl J Med 2023;388:e23.

After over 20 years as an investigator at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), Barney Graham, MD, Ph.D. retired in September 2021 as deputy director of the Vaccine Research Center and chief of the Viral Pathogenesis Laboratory. He was recently elected into the National Academy of Sciences. Earlier this year, Dr. Graham received the NAS 2022 John J. Carty Award for the Advancement of Science, which acknowledged his "groundbreaking work on a vaccine and monoclonal antibody development for COVID-19, respiratory syncytial virus, influenza, HIV, and other emerging viruses." Dr. Graham has joined the MSM faculty as a Professor in the Departments of Medicine and Microbiology, Biochemistry, and Immunology (MBI) as of May 1, 2022. In addition, Dr. Graham will serve as Senior Advisor for Global Health Equity in the Office of the President and CEO. CREDITS Theme Music

OpenAnesthesia Associate Editor Dr. Beti Asnake sits down with Dr. Tirunesh Busha, one of three pediatric anesthesiologists in Ethiopia, to discuss her career, challenges in the provision of anesthetic care in Ethiopia and her interest in pediatric anesthesiology.

Mary Stutts, Real Chemistry's Chief Global Health Equity and Inclusion Officer, is back on the show to discuss why investing in health equity makes our industry more inclusive, digitally driven, equitable, and, ultimately, more profitable.  -| The Health Equity Podcast Channel is made possible with support from Bayer G4A. Learn more about how Bayer G4A is advancing equity, access and sustainability at G4a.health -| This episode originally aired on October 13, 2022 on The Real Chemistry Podcast. Listen, follow and subscribe here.

Mary Stutts, Real Chemistry's Chief Global Health Equity and Inclusion Officer, is back on the show to discuss why investing in health equity makes our industry more inclusive, digitally driven, equitable, and, ultimately, more profitable.  -| The Health Equity Podcast Channel is made possible with support from Bayer G4A. Learn more about how Bayer G4A is advancing equity, access and sustainability at G4a.health -| This episode originally aired on October 13, 2022 on The Real Chemistry Podcast. Listen, follow and subscribe here.

HIMSS is advocating for the protection of COVID-19 telehealth flexibilities; Cerebral said its cuts would affect employees across the company, while Philips is planning on making cuts of its own.

Mary Stutts, Real Chemistry's Chief Global Health Equity and Inclusion Officer, is back on the show to discuss why investing in health equity makes our industry more inclusive, digitally driven, equitable, and, ultimately, more profitable. 

Musculoskeletal (MSK) pain and osteoarthritis are clinically common in general practice, but with the new draft NICE guideline on osteoarthritis (published in April 2022) recommending a move away from pharmacological treatments and instead promoting self-management, some GPs have been left wondering how best to manage MSK pain going forwards . In this week's episode, Dr. Imran Sajid talks to us about the importance of educating patients on what arthritis really is – moving away from the term “wear and tear” – and of taking a thorough history of a patient's pain journey in consultations. He also gives practical advice on how we might approach non-pharmacological management of MSK pain with our patients. Our guest: Imran Sajid is a GP with a special interest in MSK medicine. He is the clinical lead in MSK & Diagnostics for NHS North West London, an adjunct lecturer in Health Policy at the University of Global Health Equity, as well as being a qualified personal trainer. Further reading: ‘Osteoarthritis: assessment and management, draft for consultation, April 2022'. NICE. 2022. https://www.nice.org.uk/guidance/gid-ng10127/documents/draft-guideline ‘The tear, flare, and repair model of osteoarthritis'. BMJ 2022;377:o1028. https://www.bmj.com/content/377/bmj.o1028

With its mission to bring the benefits of modern medicine to places that have been impacted by poverty and injustice, Partners In Health has been at the forefront of the battle for global health equity since it began in 1987.  Founded by a group of like-minded physicians and philanthropists, including the late Dr. Paul Farmer, it has focused on strengthening health systems in the communities that need them most. “Paul really saw that the link between academia and clinical and the community had to be a deliberate and authentic one," says Dr. Sheila Davis, CEO of Partners In Health. Dr. Davis began her work as a nurse fighting the HIV pandemic in the 1980s and has since built an amazing career in healthcare and philanthropy, holding multiple leadership roles at Partners In Health over the past decade. In this informative conversation with host Shiv Gaglani, she gives us an inside look at the organization's current work, provides insights on what it takes to strengthen healthcare systems, and stresses the importance of taking a community-grounded approach.  Mentioned in this episode: https://www.pih.org/

Vulture culture is the practice of stealing something, rebranding it as something else, then selling or forcing it back onto the people it was stolen from. In today's episode, fellows Soinato Leboo and Gretchen Walch ask: How does this dynamic manifest today in music, religion, and intellectual property?Their guests are Oluwatomi and Estegent, classmates of Gretchen's at the University of Global Health Equity.  Books, Links, & ArticlesLaibon: An Anthropologist's Journey with Samburu Diviners of Kenya by Elliot M. Fratkin   “Kericho Letter”   Billboard U.S. Afrobeats Songs    “Beyond African Royalty” by Takondwa Semphere   “WizKid fans debate over Justin Bieber's 'Afrobeats-inspired' performance”   Episode 1: Nice tribal wear. Now take it off. By The Stoop Podcast    “How Africa Is Changing Faith Around the World” by Philip Jenkins 

What are the colonial legacies in global health? And what impact have they had on how some health and health research programmes are run in Africa? In this episode, we speak to two visionary women leaders who tell us what's wrong in global health and give concrete steps toward more equitable and inclusive partnerships. Host Garry Aslanyan speaks with the following guests:Catherine Kyobutungi, Executive Director of the African Population and Health Research Center in KenyaAgnes Binagwaho, Vice Chancellor of the University of Global Health Equity in RwandaRelated documents, transcripts and other information can be found on our website at https://tdr.who.int/global-health-matters-podcast/actions-for-decolonizing-global-healthWe are keen to engage with you, our listeners, at every step of the way – please feel free to suggest topics and questions to be discussed and share your feedback by dropping us a line at TDRpod@who.int.Follow @TDRnews on Twitter, TDR on LinkedIn and @ghm_podcast on Instagram for updates.Disclaimer: The views, information, or opinions expressed during the Global Health Matters podcast series are solely those of the individuals involved and do not necessarily represent those of TDR or the World Health Organization.

Welcome to episode 76 [originally broadcast on Wednesday 12 January 2022] of #mhTV​​​​​​​​​​​​​. This week Vanessa Gilmartin-Garrity, Nicky Lambert spoke with guest Dr. Marion Lynch to about the 'I'm Fine' Art Project. Marion currently works in global health systems development and clinical education. She is a general and mental health registered nurse and Visiting Professor at University of West London and University of Global Health Equity, Rwanda. She is also Trustee of the arts and health charity PIH which is where this project on images and art to support nurses' wellbeing comes from. This work includes exploring how the arts help us understand and improve health, our own, and our patients' health and wellbeing. Her Doctorate helps explore this academically and her personal experience working with colleagues and patients during COVID explains this personally. This I'm Fine Art Project comes from listening to nurses say 'I'm fine', but not meaning it, sailing with young people living with cancer and hearing them speak about their experiences during COVID and the impact nurses have had, and seeing the unrepresentative and sometimes unhelpful images of nurses in the media. Some links to follow: You can look at the Healthcare Heroes, #PortraitsForNHSHeroes via https://artsandculture.google.com/project/healthcare-heroes Some Twitter links to follow are: VG - https://twitter.com/VanessaRNMH NL - https://twitter.com/niadla​​​​​​​​​​​​​ ML - https://twitter.com/drmarionlynch Credits: Presenter: Vanessa Gilmartin-Garrity & Nicky Lambert Guest: Prof. Dr. Marion Lynch Theme music: Tony Gillam Production & Editing: David Munday (https://twitter.com/davidamunday)

This week on The Sunday Magazine with Piya Chattopadhyay • Writer Stephen Marche projects perilous future scenarios for the United States • John Koenig shares invented words for universal feelings with his Dictionary of Obscure Sorrows • Dr. Madhukar Pai urges taking a global approach to ending the COVID-19 pandemic • Acclaimed novelist Hanya Yanagihara returns with her new book To Paradise Discover more at https://www.cbc.ca/sunday

Professeure en pédiatrie, vice-chancelière de l'université Global Health Equity de Kigali, Agnès Binagwaho va coprésider la première conférence internationale sur la santé publique en Afrique (14 au 16 décembre 2021). Quels sont les enjeux de ce rendez-vous, alors que la Covid-19 révèle les inégalités en matière d'accès aux soins ? Présentation : Denise Époté. www.tv5monde.com/etsi

In this episode, the editorial team talks about Moderna's unwillingness to share its COVID-19 vaccine formula with other countries, namely low- and middle-income countries who continue to face issues accessing COVID-19 vaccines. The company said it would be more efficient for it to aim to produce more of the vaccines themselves to deliver to poorer countries. While developing countries continue to call for IP waivers on COVID-19 vaccines, and vaccine makers like Pfizer and Moderna resisting the calls, it's important to note that it isn't so easy to set up the specialized manufacturing facilities needed for production of mRNA vaccines. The team discusses these issues in the face of global vaccine inequities.Ayesha also talked about Grammy award-winning singer Mary J. Blige's efforts to help raise awareness about breast cancer during breast cancer awareness month this October. As part of her efforts, the entertainer teamed up with MedTech company Hologic, which is leading initiatives to promote equitable healthcare for women. Blige shared how breast cancer has personally affected her with the passing of her aunt from the disease, the problem of cancer not being discussed in Black communities and the fact that the disease has a 40 percent higher mortality among Black women compared to white women. Blige wants to help change this by raising awareness of the importance of early detection through annual mammograms, as well as increasing inclusion of Black women in clinical trials. Read the full articles here: Moderna Unwilling to Share COVID-19 Vaccine Formula Amid Vaccine InequitiesSinger Mary J. Blige Partners with Hologic to Raise Awareness About Early Breast Cancer Screening for Black WomenFor more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

In Epidemic Illusions: On the Coloniality of Global Public Health (MIT Press, 2020), physician-anthropologist Eugene T. Richardson explores how public health practices—from epidemiological modeling to outbreak containment—help perpetuate global inequities. This book questions the Global North's "monopoly on truth" in global public health science, making a provocative claim: that public health science manages and maintains global health inequity. Richardson, a physician and anthropologist, examines the conventional public health approach to epidemiology through the lens of a participant-observer, identifying a dogmatic commitment to the quantitative paradigm. This paradigm, he argues, plays a role in causing and perpetrating public health crises. The mechanisms of public health science--and epidemiology in particular--that set public health agendas and claim a monopoly on truth stem from a colonial, racist, and patriarchal system that had its inception in 1492. Deploying a range of rhetorical tools, including ironism, “redescriptions” of public health crises, Platonic dialogue, flash fiction, allegory, and koan, Richardson describes how epidemiology uses models of disease causation that serve protected affluence (the possessing classes) by setting epistemic limits to the understanding of why some groups live sicker lives than others—limits that sustain predatory accumulation rather than challenge it. Drawing on his clinical work in a variety of epidemics, including Ebola in West Africa and the Democratic Republic of Congo, leishmania in the Sudan, HIV/TB in southern Africa, diphtheria in Bangladesh, and SARS-CoV-2 in the United States, he concludes that the biggest epidemic we currently face is an epidemic of illusions—one that is propagated by the coloniality of knowledge production. Eugene T. Richardson, MD, PhD, is Assistant Professor of Global Health and Social Medicine at Harvard Medical School, Visiting Faculty at the University of Global Health Equity in Butaro, Rwanda, and Chair of the Lancet Commission on Reparations and Redistributive Justice. Catriona Gold is a PhD candidate in Geography at University College London. Her current work concerns the politics of travel in Cold War US; she has previously published on US intervention in the 2013-16 Ebola epidemic. She can be reached by email or on Twitter. Learn more about your ad choices. Visit megaphone.fm/adchoices

In Epidemic Illusions: On the Coloniality of Global Public Health (MIT Press, 2020), physician-anthropologist Eugene T. Richardson explores how public health practices—from epidemiological modeling to outbreak containment—help perpetuate global inequities. This book questions the Global North's "monopoly on truth" in global public health science, making a provocative claim: that public health science manages and maintains global health inequity. Richardson, a physician and anthropologist, examines the conventional public health approach to epidemiology through the lens of a participant-observer, identifying a dogmatic commitment to the quantitative paradigm. This paradigm, he argues, plays a role in causing and perpetrating public health crises. The mechanisms of public health science--and epidemiology in particular--that set public health agendas and claim a monopoly on truth stem from a colonial, racist, and patriarchal system that had its inception in 1492. Deploying a range of rhetorical tools, including ironism, “redescriptions” of public health crises, Platonic dialogue, flash fiction, allegory, and koan, Richardson describes how epidemiology uses models of disease causation that serve protected affluence (the possessing classes) by setting epistemic limits to the understanding of why some groups live sicker lives than others—limits that sustain predatory accumulation rather than challenge it. Drawing on his clinical work in a variety of epidemics, including Ebola in West Africa and the Democratic Republic of Congo, leishmania in the Sudan, HIV/TB in southern Africa, diphtheria in Bangladesh, and SARS-CoV-2 in the United States, he concludes that the biggest epidemic we currently face is an epidemic of illusions—one that is propagated by the coloniality of knowledge production. Eugene T. Richardson, MD, PhD, is Assistant Professor of Global Health and Social Medicine at Harvard Medical School, Visiting Faculty at the University of Global Health Equity in Butaro, Rwanda, and Chair of the Lancet Commission on Reparations and Redistributive Justice. Catriona Gold is a PhD candidate in Geography at University College London. Her current work concerns the politics of travel in Cold War US; she has previously published on US intervention in the 2013-16 Ebola epidemic. She can be reached by email or on Twitter. Learn more about your ad choices. Visit megaphone.fm/adchoices

In Epidemic Illusions: On the Coloniality of Global Public Health (MIT Press, 2020), physician-anthropologist Eugene T. Richardson explores how public health practices—from epidemiological modeling to outbreak containment—help perpetuate global inequities. This book questions the Global North's "monopoly on truth" in global public health science, making a provocative claim: that public health science manages and maintains global health inequity. Richardson, a physician and anthropologist, examines the conventional public health approach to epidemiology through the lens of a participant-observer, identifying a dogmatic commitment to the quantitative paradigm. This paradigm, he argues, plays a role in causing and perpetrating public health crises. The mechanisms of public health science--and epidemiology in particular--that set public health agendas and claim a monopoly on truth stem from a colonial, racist, and patriarchal system that had its inception in 1492. Deploying a range of rhetorical tools, including ironism, “redescriptions” of public health crises, Platonic dialogue, flash fiction, allegory, and koan, Richardson describes how epidemiology uses models of disease causation that serve protected affluence (the possessing classes) by setting epistemic limits to the understanding of why some groups live sicker lives than others—limits that sustain predatory accumulation rather than challenge it. Drawing on his clinical work in a variety of epidemics, including Ebola in West Africa and the Democratic Republic of Congo, leishmania in the Sudan, HIV/TB in southern Africa, diphtheria in Bangladesh, and SARS-CoV-2 in the United States, he concludes that the biggest epidemic we currently face is an epidemic of illusions—one that is propagated by the coloniality of knowledge production. Eugene T. Richardson, MD, PhD, is Assistant Professor of Global Health and Social Medicine at Harvard Medical School, Visiting Faculty at the University of Global Health Equity in Butaro, Rwanda, and Chair of the Lancet Commission on Reparations and Redistributive Justice. Catriona Gold is a PhD candidate in Geography at University College London. Her current work concerns the politics of travel in Cold War US; she has previously published on US intervention in the 2013-16 Ebola epidemic. She can be reached by email or on Twitter. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine

In Epidemic Illusions: On the Coloniality of Global Public Health (MIT Press, 2020), physician-anthropologist Eugene T. Richardson explores how public health practices—from epidemiological modeling to outbreak containment—help perpetuate global inequities. This book questions the Global North's "monopoly on truth" in global public health science, making a provocative claim: that public health science manages and maintains global health inequity. Richardson, a physician and anthropologist, examines the conventional public health approach to epidemiology through the lens of a participant-observer, identifying a dogmatic commitment to the quantitative paradigm. This paradigm, he argues, plays a role in causing and perpetrating public health crises. The mechanisms of public health science--and epidemiology in particular--that set public health agendas and claim a monopoly on truth stem from a colonial, racist, and patriarchal system that had its inception in 1492. Deploying a range of rhetorical tools, including ironism, “redescriptions” of public health crises, Platonic dialogue, flash fiction, allegory, and koan, Richardson describes how epidemiology uses models of disease causation that serve protected affluence (the possessing classes) by setting epistemic limits to the understanding of why some groups live sicker lives than others—limits that sustain predatory accumulation rather than challenge it. Drawing on his clinical work in a variety of epidemics, including Ebola in West Africa and the Democratic Republic of Congo, leishmania in the Sudan, HIV/TB in southern Africa, diphtheria in Bangladesh, and SARS-CoV-2 in the United States, he concludes that the biggest epidemic we currently face is an epidemic of illusions—one that is propagated by the coloniality of knowledge production. Eugene T. Richardson, MD, PhD, is Assistant Professor of Global Health and Social Medicine at Harvard Medical School, Visiting Faculty at the University of Global Health Equity in Butaro, Rwanda, and Chair of the Lancet Commission on Reparations and Redistributive Justice. Catriona Gold is a PhD candidate in Geography at University College London. Her current work concerns the politics of travel in Cold War US; she has previously published on US intervention in the 2013-16 Ebola epidemic. She can be reached by email or on Twitter. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science-technology-and-society

In Epidemic Illusions: On the Coloniality of Global Public Health (MIT Press, 2020), physician-anthropologist Eugene T. Richardson explores how public health practices—from epidemiological modeling to outbreak containment—help perpetuate global inequities. This book questions the Global North's "monopoly on truth" in global public health science, making a provocative claim: that public health science manages and maintains global health inequity. Richardson, a physician and anthropologist, examines the conventional public health approach to epidemiology through the lens of a participant-observer, identifying a dogmatic commitment to the quantitative paradigm. This paradigm, he argues, plays a role in causing and perpetrating public health crises. The mechanisms of public health science--and epidemiology in particular--that set public health agendas and claim a monopoly on truth stem from a colonial, racist, and patriarchal system that had its inception in 1492. Deploying a range of rhetorical tools, including ironism, “redescriptions” of public health crises, Platonic dialogue, flash fiction, allegory, and koan, Richardson describes how epidemiology uses models of disease causation that serve protected affluence (the possessing classes) by setting epistemic limits to the understanding of why some groups live sicker lives than others—limits that sustain predatory accumulation rather than challenge it. Drawing on his clinical work in a variety of epidemics, including Ebola in West Africa and the Democratic Republic of Congo, leishmania in the Sudan, HIV/TB in southern Africa, diphtheria in Bangladesh, and SARS-CoV-2 in the United States, he concludes that the biggest epidemic we currently face is an epidemic of illusions—one that is propagated by the coloniality of knowledge production. Eugene T. Richardson, MD, PhD, is Assistant Professor of Global Health and Social Medicine at Harvard Medical School, Visiting Faculty at the University of Global Health Equity in Butaro, Rwanda, and Chair of the Lancet Commission on Reparations and Redistributive Justice. Catriona Gold is a PhD candidate in Geography at University College London. Her current work concerns the politics of travel in Cold War US; she has previously published on US intervention in the 2013-16 Ebola epidemic. She can be reached by email or on Twitter. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

In Epidemic Illusions: On the Coloniality of Global Public Health (MIT Press, 2020), physician-anthropologist Eugene T. Richardson explores how public health practices—from epidemiological modeling to outbreak containment—help perpetuate global inequities. This book questions the Global North's "monopoly on truth" in global public health science, making a provocative claim: that public health science manages and maintains global health inequity. Richardson, a physician and anthropologist, examines the conventional public health approach to epidemiology through the lens of a participant-observer, identifying a dogmatic commitment to the quantitative paradigm. This paradigm, he argues, plays a role in causing and perpetrating public health crises. The mechanisms of public health science--and epidemiology in particular--that set public health agendas and claim a monopoly on truth stem from a colonial, racist, and patriarchal system that had its inception in 1492. Deploying a range of rhetorical tools, including ironism, “redescriptions” of public health crises, Platonic dialogue, flash fiction, allegory, and koan, Richardson describes how epidemiology uses models of disease causation that serve protected affluence (the possessing classes) by setting epistemic limits to the understanding of why some groups live sicker lives than others—limits that sustain predatory accumulation rather than challenge it. Drawing on his clinical work in a variety of epidemics, including Ebola in West Africa and the Democratic Republic of Congo, leishmania in the Sudan, HIV/TB in southern Africa, diphtheria in Bangladesh, and SARS-CoV-2 in the United States, he concludes that the biggest epidemic we currently face is an epidemic of illusions—one that is propagated by the coloniality of knowledge production. Eugene T. Richardson, MD, PhD, is Assistant Professor of Global Health and Social Medicine at Harvard Medical School, Visiting Faculty at the University of Global Health Equity in Butaro, Rwanda, and Chair of the Lancet Commission on Reparations and Redistributive Justice. Catriona Gold is a PhD candidate in Geography at University College London. Her current work concerns the politics of travel in Cold War US; she has previously published on US intervention in the 2013-16 Ebola epidemic. She can be reached by email or on Twitter. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/world-affairs

In Epidemic Illusions: On the Coloniality of Global Public Health (MIT Press, 2020), physician-anthropologist Eugene T. Richardson explores how public health practices—from epidemiological modeling to outbreak containment—help perpetuate global inequities. This book questions the Global North's "monopoly on truth" in global public health science, making a provocative claim: that public health science manages and maintains global health inequity. Richardson, a physician and anthropologist, examines the conventional public health approach to epidemiology through the lens of a participant-observer, identifying a dogmatic commitment to the quantitative paradigm. This paradigm, he argues, plays a role in causing and perpetrating public health crises. The mechanisms of public health science--and epidemiology in particular--that set public health agendas and claim a monopoly on truth stem from a colonial, racist, and patriarchal system that had its inception in 1492. Deploying a range of rhetorical tools, including ironism, “redescriptions” of public health crises, Platonic dialogue, flash fiction, allegory, and koan, Richardson describes how epidemiology uses models of disease causation that serve protected affluence (the possessing classes) by setting epistemic limits to the understanding of why some groups live sicker lives than others—limits that sustain predatory accumulation rather than challenge it. Drawing on his clinical work in a variety of epidemics, including Ebola in West Africa and the Democratic Republic of Congo, leishmania in the Sudan, HIV/TB in southern Africa, diphtheria in Bangladesh, and SARS-CoV-2 in the United States, he concludes that the biggest epidemic we currently face is an epidemic of illusions—one that is propagated by the coloniality of knowledge production. Eugene T. Richardson, MD, PhD, is Assistant Professor of Global Health and Social Medicine at Harvard Medical School, Visiting Faculty at the University of Global Health Equity in Butaro, Rwanda, and Chair of the Lancet Commission on Reparations and Redistributive Justice. Catriona Gold is a PhD candidate in Geography at University College London. Her current work concerns the politics of travel in Cold War US; she has previously published on US intervention in the 2013-16 Ebola epidemic. She can be reached by email or on Twitter. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/anthropology

In Epidemic Illusions: On the Coloniality of Global Public Health (MIT Press, 2020), physician-anthropologist Eugene T. Richardson explores how public health practices—from epidemiological modeling to outbreak containment—help perpetuate global inequities. This book questions the Global North's "monopoly on truth" in global public health science, making a provocative claim: that public health science manages and maintains global health inequity. Richardson, a physician and anthropologist, examines the conventional public health approach to epidemiology through the lens of a participant-observer, identifying a dogmatic commitment to the quantitative paradigm. This paradigm, he argues, plays a role in causing and perpetrating public health crises. The mechanisms of public health science--and epidemiology in particular--that set public health agendas and claim a monopoly on truth stem from a colonial, racist, and patriarchal system that had its inception in 1492. Deploying a range of rhetorical tools, including ironism, “redescriptions” of public health crises, Platonic dialogue, flash fiction, allegory, and koan, Richardson describes how epidemiology uses models of disease causation that serve protected affluence (the possessing classes) by setting epistemic limits to the understanding of why some groups live sicker lives than others—limits that sustain predatory accumulation rather than challenge it. Drawing on his clinical work in a variety of epidemics, including Ebola in West Africa and the Democratic Republic of Congo, leishmania in the Sudan, HIV/TB in southern Africa, diphtheria in Bangladesh, and SARS-CoV-2 in the United States, he concludes that the biggest epidemic we currently face is an epidemic of illusions—one that is propagated by the coloniality of knowledge production. Eugene T. Richardson, MD, PhD, is Assistant Professor of Global Health and Social Medicine at Harvard Medical School, Visiting Faculty at the University of Global Health Equity in Butaro, Rwanda, and Chair of the Lancet Commission on Reparations and Redistributive Justice. Catriona Gold is a PhD candidate in Geography at University College London. Her current work concerns the politics of travel in Cold War US; she has previously published on US intervention in the 2013-16 Ebola epidemic. She can be reached by email or on Twitter. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/critical-theory

In Epidemic Illusions: On the Coloniality of Global Public Health (MIT Press, 2020), physician-anthropologist Eugene T. Richardson explores how public health practices—from epidemiological modeling to outbreak containment—help perpetuate global inequities. This book questions the Global North's "monopoly on truth" in global public health science, making a provocative claim: that public health science manages and maintains global health inequity. Richardson, a physician and anthropologist, examines the conventional public health approach to epidemiology through the lens of a participant-observer, identifying a dogmatic commitment to the quantitative paradigm. This paradigm, he argues, plays a role in causing and perpetrating public health crises. The mechanisms of public health science--and epidemiology in particular--that set public health agendas and claim a monopoly on truth stem from a colonial, racist, and patriarchal system that had its inception in 1492. Deploying a range of rhetorical tools, including ironism, “redescriptions” of public health crises, Platonic dialogue, flash fiction, allegory, and koan, Richardson describes how epidemiology uses models of disease causation that serve protected affluence (the possessing classes) by setting epistemic limits to the understanding of why some groups live sicker lives than others—limits that sustain predatory accumulation rather than challenge it. Drawing on his clinical work in a variety of epidemics, including Ebola in West Africa and the Democratic Republic of Congo, leishmania in the Sudan, HIV/TB in southern Africa, diphtheria in Bangladesh, and SARS-CoV-2 in the United States, he concludes that the biggest epidemic we currently face is an epidemic of illusions—one that is propagated by the coloniality of knowledge production. Eugene T. Richardson, MD, PhD, is Assistant Professor of Global Health and Social Medicine at Harvard Medical School, Visiting Faculty at the University of Global Health Equity in Butaro, Rwanda, and Chair of the Lancet Commission on Reparations and Redistributive Justice. Catriona Gold is a PhD candidate in Geography at University College London. Her current work concerns the politics of travel in Cold War US; she has previously published on US intervention in the 2013-16 Ebola epidemic. She can be reached by email or on Twitter. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/book-of-the-day

Pine Tree Foundation Endowed Lecture In conversation with Dr. Steven Larson, Associate Professor of Emergency Medicine at the Hospital of the University of Pennsylvania. Acclaimed for his ''exceptional empathy and care'' (Boston Globe) as a physician, anthropologist, and infectious-disease expert, Paul Farmer is the Kolokotrones University Professor and Chair of Global Health and Social Medicine at Harvard University and is chief of the Division of Global Health Equity at Boston's Brigham and Women's Hospital. He is also a founding director of Partners In Health, an international non-profit organization that provides medical care and advocacy for those living in poverty. The recipient of the Public Welfare Medal from the National Academy of Sciences, a MacArthur Fellowship, and honorary doctorates from numerous universities, Farmer is the author of Infections and Inequalities: The Modern Plagues and Pathologies of Power: Health, Human Rights, and the New War on the Poor. In Fevers, Feuds, and Diamonds, he melds firsthand reportage, science, and advocacy into a narrative account of 2014's deadly Ebola outbreak in Sierra Leone, Liberia, and Guinea. Books may be purchased through the Joseph Fox Bookshop (recorded 6/14/2021)

Why are there so few Black, Latinx, and Indigenous healthcare professionals in the American healthcare system? How does mistrust in medical professionals arise from childhood within marginalized communities? In this series on healthcare and social disparities, Dr. Jill Wener, a board-certified Internal Medicine specialist, meditation expert, and tapping practitioner, interviews experts in multiple fields relating to social justice and anti-racism. In this episode, Jill interviews Susan Lopez MD, the Assistant Professor in the Division of Hospital Medicine and the Division of Community and Global Health Equity in the Department of Internal Medicine. Their discussion explores the systemic reasons, starting in childhood, that shape a distrust in medical professionals by Black, Latinx, and Indigenous peoples. Dr. Lopez calls out the importance of “pathway programs” to increase minority representation in healthcare. She explains that success is not a linear process and the commonalities in experiences of marginalized communities as to why there's a need for inequity and inclusion work in healthcare for both patients and healthcare professionals. Dr. Susan Lopez is Assistant Professor in the Division of Hospital Medicine and the Division of Community and Global Health Equity, both in the Department of Internal Medicine. She serves on the Executive Admissions Committee and its Diversity Work Group for Rush Medical College. She seeks to support learners who identify as Underrepresented in Medicine as the Diversity Officer and as a faculty advisor to the Latino Medical Student Association (LMSA). LINKS Follow Dr. Lopez on Twitter: @susanlopezmd Why Are All The Black Kids Sitting Together in the Cafeteria? by Beverly Daniel Tatum ** You can learn more about Dr. Wener and her online meditation and tapping courses at www.jillwener.com, and you can learn more about her online social justice course, Conscious Anti Racism: Tools for Self-Discovery, Accountability, and Meaningful Change at https://theresttechnique.com/courses/conscious-anti-racism. Find the Conscious Anti-Racism book at https://tinyurl.com/y689563j Join her Conscious Anti-Racism facebook group: https://www.facebook.com/groups/307196473283408/ Follow her on: Instagram at www.instagram.com/jillwenerMD Twitter at www.twitter.com/jillwenerMD Facebook at www.facebook.com/jillwenerMDmeditation LinkedIn at www.linkedin.com/in/jill-wener-md-682746125/

Link to SMOA listener survey: bit.ly/SMOAsurvey We're joined today by the incredible Agnes Binagwaho, who speaks with us about gender equity and religion before, during, and after the colonial era, the positive power of institutions like the University of Global Health Equity, the importance of teaching leadership and implementation science, and the importance of good systems in care for the most vulnerable. She talks about demystifying healthcare systems, explaining how Rwanda has seen some of the fastest declines in mortality in human history, the importance of human rights, and the importance of trust, accountability, and community (including community health workers). "Tell the truth!" Agnes Binagwaho MD, M(Ped), PhD is the Vice Chancellor of the University of Global Health Equity, the former Minister of Health of Rwanda and former Professor of Global Health Equity at UGHE. She also is a trained pediatrician, Senior Lecture at the Department of Global Health and Social Medicine at Harvard Medical School, a member of the US National Academy of Medicine and the African Academy of Sciences, and was Co-Chair of the UN task force on the Millennium Development Goals Project for HIV/AIDS and Access to Essential Medicines (among many, many other positions). Resources related to this episode: A. Binagwaho "How Women are Revolutionizing Rwanda" (TED Talk, 2020), bit.ly/3w5hOxB A. Binagwaho "Lessons from Rwanda's Journey to an Equitable Health System" (TED Talk, 2017), bit.ly/3znfhRw Farmer P E et al. Reduced premature mortality in Rwanda: lessons from success. BMJ 2013, bit.ly/2TSvuOj Binagwaho A et al. Rwanda 20 years on: investing in life. Lancet 2014, bit.ly/3cv7N58

With a global surge in new COVID-19 cases, the U.S. has been facing mounting pressure to share medical equipment and vaccines with other countries. The Biden administration just announced plans to make 60 million doses of the AstraZeneca vaccine available around the world. We talk to the CEO of Mercy Corps, Tjada Mckenna, about global health equity in the pandemic.

As part of our Setbacks series examining the impact of COVID-19 on global development, Paul Farmer explains why he is still optimistic after working for 40 years to end global health inequities. Paul Farmer is a professor at Harvard Medical School, Chief of Global Health Equity at Brigham and Women’s Hospital in Boston, and Co-Founder of Partners In Health. He believes that solutions flow from addressing social pathologies along with pathogens. Looking to learn more about global health? Check out these links: Partners In Health Fevers, Feuds, And Diamonds: Ebola and the Ravages of History by Paul Farmer          Bending the Arc, Netflix Pragmatic Solidarity, by Paul Farmer for The Center for Compassion and Global Health Rwanda starts administering second doses of AstraZeneca vaccines Partners in Heath, Haiti Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Geoff Martha, Chairman and Chief Executive Officer, Medtronic Paurvi Bhatt, President, Medtronic Foundation Jackie Boucher, President, Children’s HeartLink

Summary In this episode of Clinical Problem Solvers: Anti-Racism in Medicine, we are joined by Michelle Morse, MD, MPH, Deputy Commissioner for the Center for Health Equity and Community Wellness (CHECW) and the inaugural Chief Medical Officer at the NYC Department of Health and Mental Hygiene (NYCDOHMH), and Paul Farmer, MD, PhD, Kolokotrones University Professor… Read More »Episode 169: Antiracism in Medicine Series – Episode 7 – Antiracism, Global Health Equity, and the COVID-19 Response

American Indians and Alaska natives face challenging economic, environmental, and political conditions that are in many ways similar to those experienced in developing countries. About 37%, for example, of Navajo or Dine people live in poverty. Access to preventive services such as cancer screening, immunizations, and early detection is often limited. And patients must travel long distances to obtain medical services. The situation is made worse by the lack of access to healthy foods. As a result, the life expectancy for American Indians is about six years shorter than that for the general population. Additionally, American Indians suffer disproportionately high rates of obesity, diabetes, heart disease, mental illness, and substance abuse. Today, we are speaking with two impressive people working to change that, Dr. Sonya Shin and Kymie Thomas. They run the Navajo Nation Community Outreach and Patient Empowerment or COPE Program. This is a community-based outreach and food security program made possible through a formal collaboration between Brigham and Women's Health in Boston, Tribal Leadership and Indian Health Services to address health disparities in the Navajo Nation.   Interview Summary   So Sonya, let me begin with you. As a physician at Brigham and Women's Hospital and a professor at the Harvard School of Medicine, can you explain why you founded the COPE Program and the impact that it's having?   I started off my work abroad doing global health. And as I began to learn about how to partner with communities to address health issues, I became really interested in turning my attention toward some of the issues that are facing our communities here in the United States. So we were just really excited and honored that about 10 years ago we were invited to partner with Navajo Nation. The idea was to really work in solidarity with the tribal leadership, with community partners, and health care providers to address some of the health disparities that you described before.   Kymie, I'd like to ask you as a member of the Navajo Nation, and the health professional and coordinator of the program, you're in a unique position to help our leaders understand the experience of living in a food desert on a reservation. Can you describe more about this?   I grew up on the Navajo reservation, which is a larger reservation. It encompasses three states, New Mexico, Utah, and Arizona. The distance and traveling between the communities and to the nearest towns is about two hours. So within these communities, there's a limited amount of grocery stores. People purchase foods in the convenience stores. And as you are all aware, most of the convenience stores typically only have processed foods and nutrient dense foods. And they offer little to very little variety when it comes to fruits and vegetables. So with families living in a remote area, the delivery of these fruits and vegetables to these stores drives the cost of transportation to these families. So when they go in to purchase their food, they're looking at foods that will last longer for their families. And some of the foods there aren't very great quality. So most of the families have to travel more than two hours to be able to obtain these foods. My family didn't have electricity until just recently. So in my family, we would have to travel into Gallup, which is for us a 45-minute drive. And we wouldn't be able to purchase frozen fruits or vegetables, mainly fresh ones, but even then it wouldn't last very long. So my parents would have to purchase foods that would last our family longer. So like potatoes and canned meats because you typically don't need refrigeration for that type of food. And so I think for the people who live on the reservation, a pressing issue to not be able to purchase these healthy foods that we tell them to consume when they don't have access to plumbing or electricity. So a lot of those factors combined really play a huge part in some of the challenges that our families face in obtaining healthy foods in a food desert.   So thank you for that description. Sonya, let me ask you, what is the COPE Program all about, and how does it go about trying to close these gaps for proper nutrition and while being centrally located in what's this food desert that Kymie just described?   When we started the program, we weren't actually thinking about addressing food insecurity. I was thinking about, okay, I'm a doctor. You know, how do I address diabetes? How are we going to be dealing with the rising rates of childhood obesity? But it became quickly apparent that a patient of mine with diabetes doesn't need to be told that they're supposed to eat fresher fruits and vegetables. They know this. And so we quickly became aware that in order to start to move the needle around some of these health issues, we were going to have to shift our focus from just trying to increase access to health care to also increasing access to healthy foods and actually making it possible for patients to make these changes that they want to make. We thought about it for some time and we listened to a lot of different partners. And what we heard is that on the one hand, really important to think about these individual families that are living deep in the reservation, oftentimes with very few options, but also to think about how do we create an approach that doesn't just push all of the resources out to the border towns. So creating ways for people to travel outside of the reservation and spend their money, say, at a neighboring grocery store, it doesn't actually change the actual status of the community on Navajo.   So we decided that the Fruit and Vegetable Prescription Program that Kymie runs might be an interesting approach for several reasons. One is that healthcare providers want to do something. When I see a patient in clinic and I know that they often don't have healthy foods, especially after the first week of the month when they have fewer options, no electricity, et cetera, I want to be able to offer that family something. So engaging healthcare providers as implementers seemed very appealing. And then second, the idea of being able to use the vouchers that families receive to also kind of infuse economic stimulation to the local food system and the local economy was very appealing because that meant that over time, hopefully we could actually have a lasting impact on a more kind of thriving and robust food system. You know, I would invite Kymie to describe a little bit more of that Fruit and Vegetable Prescription Program or FVRx as we call it. To us it seemed like a very interesting model for a cross-sectoral approach to address both the food system on Navajo Nation, and also health disparities.   Kymie, please do tell us more about the program.   We work closely with the providers addressing a family that's in need. So finding that area where there is a need and locating those families and being able to work closely with our store team here in the organization to ensure that our partnering stores where sites are able to redeem vouchers, that they are also fully equipped with a wholesome variety of fruits and vegetables to be able to meet the selection from our voucher program, and not only for our participants, but basically anyone who comes into the stores to purchase food. You know, when they see that there is a bigger variety of fruits and vegetables, they're more than likely going to be able to purchase that as opposed to just bananas and oranges that convenience stores normally have. And then also creating partnerships with our local growers so that families are aware that they can find vendors in their communities who sell locally grown produce. And another big emphasis is also incorporating more of our traditional foods back into our diets. So, you know, corn, fresh fruits, and vegetables like carrots, things that we have normally eaten just re-introducing that back into the diet as an indigenous community.   Sonya, is it too early to know what kind of impact this is having?   Well, we're starting to generate impact. And I can describe some of the data that we're seeing. We're really interested in real world results as opposed to a clinical trial, but what we are seeing are, I think, pretty promising. So to give you a sense, we did ask that all of the clinics prioritize families with young kids. So either families with a pregnant mom or with a child that's under age six. And we did that because we felt that the program would have the greatest impact on the health outcomes of that specific family. If we targeted really early in the life course of the child, it's an opportunity where there's a lot of positive and motivation for change, and families are very excited to make changes for their children. So that said, when we've looked at the families, not surprisingly, three quarters of the families are actually food insecure and that's actually similar to other data that we've seen published about Navajo Nation. And after the six-month program, we've definitely been able to demonstrate that fruit and vegetable consumption is increasing among both the kids and the pregnant moms.    I think one of the things that's most exciting of the data that we've seen is the change in the body mass index among the children. So we know that childhood obesity is associated with food insecurity. So it's not surprising that we're facing high rate of childhood obesity, as you mentioned before, Kelly. Among children who are enrolled with an initial weight that classifies them as overweight or obese, actually 38% of them achieved a healthy weight after six months. And I'm not a pediatrician, but I've been told by my colleagues who are running the program, that for them, it's really one of the most impactful programs that they've had the opportunity to implement with their families. The other thing that we're kind of interested in and we're just starting to see some of this data now is the spillover effect that Kymie mentioned.   So a family can participate in the program for six months, but what we're really after is changing the options out there at the community level for those families beyond the program. And then for all of the community members. So if there's a small little convenience store or trading post, that's really the only thing around for like say 60 miles, we want to change the variety, the options, the quality of the produce that's available in those stores by driving up demand, and therefore bringing up supply. So we've actually looked at shoppers that are leaving these stores and compared stores that are part of this program to stores that are not participating. We're seeing that just generic shoppers, so these aren't people who are actually enrolled in the program, are actually purchasing more fruits and vegetables from participating stores. So our hope is that over time, if we can start to change the food environment at the community level, that we could actually have an even greater impact at the population level on some of these health issues.   You know, the number that you gave, two, or three quarters, rather, of households being food insecure is incredibly discouraging, but it's really nice that you have such encouraging findings. It's very impressive what you're reporting so far. Let me ask you both a question. Sometimes relationships between organizations outside a community, like a university, and what goes on in the community, it doesn't work very well or it's very challenging to work through issues of trust and things like that. I'm curious from both of your points of view, how did you go about establishing trust, developing working relationships, creating a program that the community would actually embrace?   Having Navajo representation within the organization to help deliver the program has been really helpful. So I think with a lot of our families, it's just reassuring to them seeing someone that is the same as them, you know, me being Navajo also, they're comfortable with us coming out to families. And I think just us understanding and having that connection really has allowed the families to become more comfortable with the providers and the outside personnel. And there are some areas where a lot of the health professionals that make it up are also Native American or specifically Navajo. Just having someone similar to them and knowing, understanding where they're coming from really helps them to embrace the fact that we are here to help them. We only want for them to be healthier and that we are hoping to establish a healthier nation. We are trying to change these health disparities. We are not necessarily trying to change their whole lifestyle, but more of just incorporating more fruits and vegetables, slower steps.   And Sonya, from your point of view, how do you see this process playing out and issues like trust working?   I'm glad you bring it up. And I appreciate Kymie's comments because I think it's really key to any meaningful work when serving other communities. And I think Kymie's testament to being a member of the Navajo Nation and being able to, not only build that trust as a frontline staff, but also given that opportunity to advance her own career and have the option of coming back and working in public health has been one of the important achievements of our organization.   I can say from my own standpoint as a provider and as somebody who is not from the community. With patients, it took me about four years to actually get any trust with the patients that I see in clinic because they're so used to having providers come for about three years, which is about how long it takes to pay off your loans, and then to just cycle on out. And so I think there's this important role of just being present, and constant, and really listening.   Most of our programs took a long time to germinate because we had to really just spend a fair amount of time listening to others and make sure that we were finding an approach or a strategy or a program that would respond to those needs and not actually become interventions that sort of circumvent or undermine other movements that are happening. You know, we spent a lot of time thinking about like, well, who's in the food space? Who's doing this kind of work? How can we not be the frontline providers, but how can we be the folks who are kind of infusing additional resources or ideas to build the capacity among folks who are already here in the community? I think that's been a really important approach that we've taken over time. And it's taken us 10 years to get this far. And, you know, I hope that the fact that we do have a fair amount of trust among providers and also with the Navajo Nation leadership with whom we consult quite frequently, is kind of a testament to that approach of partnership.   Well, thank you. Kymie, I'd like to come back to you in just a moment and ask you about barriers that you encountered while the program was being implemented, but before I get to that, Sonya, do you believe that this is a model program that can be replicated elsewhere? And are you two working to get this program to other communities?   Yeah, I think from the very beginning, we were interested in choosing something that had the potential to be replicable to other Indigenous communities. And I should mention that FVRx, this Fruit and Vegetable Prescription Program is not unique. Like we're not the only ones doing it. There are many different communities across the United States that offer prescription produce within healthcare settings. To our knowledge, this might be the only one being offered in a Native community, but from the very beginning, we've really tried to think about, okay, how can we create materials, generate evidence, think about flexibility that will allow the program if it's successful to then be transmitted to other indigenous communities? And I know Kymie's received a lot of interest and inquiries from other Tribes. I think the key take-home for us has been that every community has different strengths and different needs. And we've even seen that across Navajo. If we have 12 different clinics that are running the program, there's a lot of heterogeneity of the program because each clinic has different teams that want to implement. They have different priorities, and they also have different gaps. So I think we've really tried to create a program that has parameters that are core, but has a lot of breathing room for flexibility and adaptation, so that our hope is it will be easier for other communities to take the model and then to say, "Okay, well, what's going to work in our community? "What's my priority here? "Who's the team that I envision doing this work?" So that's a future learning step for us too.   So Kymie, what are some of the barriers that you and your team encountered as you were implementing the program?   So as we are going across the reservation and implementing the program, we have started to notice a lot of good indicators of the work that we are doing. For instance, no bandwidth. Right now, we are a two-person team right now, and we are expanding to three, hopefully in the future. But, you know, with the increase in popularity of the program across the reservation, it's hard to keep up with that demand. So finding the bandwidth to be able to keep the program and quality of the program going, it's been really challenging. But it's good that the program is growing and that we are needing extra hands.   And then also, just finding compatible platforms that work for everyone. So what might work here on a border town, because we have no internet capability, might not work for another clinic or another community health team that's based six hours away, more in the middle of the reservation. So I think just finding compatible platforms to be able to communicate with everybody has been pretty difficult. And then, as the program is expanding, we are coming across other barriers, but they're all a pretty good indicator of the growth that the program is seeing overall.   Bios:   Dr. Sonya Shin, is a physician in the Division of Global Health Equity at Brigham and Woman's Hospital and professor at Harvard School of Medicine. Her research and clinical experience has focused on relieving health issues among underserved populations. She has been working in Navajo Nation since 2009 and is the executive director and founder of Community Outreach and Patient Empowerment (COPE), a non-profit and Partners In Health sister organization that aims to eliminate health disparities and improve the wellbeing of American Indians and Alaska Natives through community-based outreach and food security initiatives. Kymie Thomas is a member of the Navajo Nation, a coordinator for the COPE FVRx program and an aspiring Public Health professional. She earned a degree in Health Sciences from Sheridan College, and have 4 years' experience working within the Public Health sector. As the Fruit and Vegetable Prescription Program Specialist for the COPE FVRx Program her work has allowed the COPE Program to help increase access to healthy foods for Navajo families, and improve health outcomes in various Navajo communities that are affected by diet related diseases.  

Dr. Paul Farmer joins Nate to talk about global health equity, both with reference to past health crises, and today's. In his recent book, Fevers Feuds & Diamonds, Dr. Farmer writes about his first-hand experience responding to the Ebola crisis in West Africa, and what we can learn from it.  Dr. Farmer is professor and chair of the Department of Global Health and Social Medicine at Harvard Medical School, chief of Global Health Equity at Brigham and Women's Hospital in Boston, and co-founder and chief strategist of Partners in Health and a board member of Partners In Health Canada.Partners in Health is dedicated to bringing a high standard of public health care to the most vulnerable communities around the world, and PIH Canada is celebrating its 10th anniversary this year. The story of Dr. Farmer and colleagues Jim Yong Kim and Ophelia Dahl in founding PIH is the subject of the documentary Bending the Arc.

Grocery store employees and other essential workers had expected to soon be eligible for the COVID-19 vaccine. Now, Governor Lamont says the state’s vaccination plan will focus on age groups. Today, we talk with Dr. Deidre Gifford, Acting Commissioner of the state Department of Public Health.  We ask: how does this new plan impact vaccine equity? Do you have questions about how this vaccination plan affects you or your loved ones? GUESTS: Dr. Deidre Gifford - Acting Commissioner of Department of Public Health and Commissioner of the Department of Social Services for the State of Connecticut Dr. Bisola Ojikutu - Infectious disease specialist in the Division of Global Health Equity at Brigham and Women’s Hospital. Her work focuses on addressing disparities in infectious disease risk, prevention, care and treatment. Support the show: http://wnpr.org/donate See omnystudio.com/listener for privacy information.

Grocery store employees and other essential workers had expected to soon be eligible for the COVID-19 vaccine. Now, Governor Lamont says the state’s vaccination plan will focus on age groups. Today, we talk with Dr. Deidre Gifford, Acting Commissioner of the state Department of Public Health.  We ask: how does this new plan impact vaccine equity? Do you have questions about how this vaccination plan affects you or your loved ones? GUESTS: Dr. Deidre Gifford - Acting Commissioner of Department of Public Health and Commissioner of the Department of Social Services for the State of Connecticut Dr. Bisola Ojikutu - Infectious disease specialist in the Division of Global Health Equity at Brigham and Women’s Hospital. Her work focuses on addressing disparities in infectious disease risk, prevention, care and treatment. Support the show: http://wnpr.org/donate See omnystudio.com/listener for privacy information.

In global health, the priority setting systems that have been created, the funding structures, and power dynamics have perpetuated inequities and left so many behind for so long. We sit down with Judy Khanyola to talk about the specific ways racism, colonialism, and neocolonialism influence global health; what we must do to dismantle the system; and how we can foster partnerships that are community-led, responsive, and truly deliver durable change. (This episode was recorded in November 2020 and references events at that time.)Judy Khanyola is currently the Chair of the Center for Nursing and Midwifery at the University of Global Health Equity. She is a recognized leader with over 25 years of experience in clinical nursing and education programs. Judy has led HIV programs and provided technical support to NGOs and the public sector, working with partners and Ministries of Health in multiple countries across East, West, and Southern Africa. Watch the webinar series mentioned in the episode here:Decolonizing Global Health: Perspectives from Nurses and Midwives  Find Seed Global Health & Judy Khanyola on social media:Seed on instagram: @seedglobalhealth Seed on Twitter: @Seed_Global Seed on Facebook: @seedglobalhealth Seed on LinkedIn: Seed Global HealthJudy on Twitter: @Judyngelek

Health Reset: With Joia Mukherjee and Paul Farmer“There is no contrast between fighting against Covid and fighting for black lives” In Reimagine Series 2: Systems Reset, we’re seizing this moment to reimagine systems that are fit for purpose, and fit for everyone.In episode 2, Peter talks to global health activist Dr Joia Mukherjee about reimaging our health systems in an age of pandemics. Joia describes herself as an “ass-kicking optimist, healer, singer and lover of humanity”. She is the chief medical officer at social justice and global health non-profit Partners in Health, and much of her work explores the intersection between healthcare and racism. What does she think an equitable global health system should look like?Peter also catches up with Dr Paul Farmer, his guest in the very first episode of Reimagine, for an update on the long view of Covid-19 and what drove him to write his new book Fevers, Feuds and Diamonds: Ebola and the Ravages of History.Reimagine is a podcast about people who are inventing the future. Presented by Oxford Answers and the Skoll Centre for Social Entrepreneurship at the University of Oxford’s Saïd Business School. New episodes on Thursdays.Featuring:Dr Joia Mukherjee (@JoiaMukherjee), chief medical officer, Partners in Health; Associate Professor, Department of Global Health and Social Medicine, Harvard Medical School; Associate Professor, Division of Global Health Equity, Brigham and Women’s Hospital.Dr Paul Farmer, co-founder, Partners in Health.Host:Peter Drobac (@peterdrobac), Director of the @SkollCentre for Social Entrepreneurship, Saïd Business School at the University of Oxford.Resources:Fevers, Feuds and Diamonds by Dr Paul FarmerPartners in HealthBending The Arc Introduction to Global Health Delivery by Dr Joia MukherjeeNecropolitics, Achille MbembeWant to learn more about the show? Check out www.reimaginepodcast.com.Have a question for Peter? Email him at peter@reimaginepodcast.com.Credits:Producer/editor – Eve Streeter for Stabl

The Berkman Klein Center for Internet & Society at Harvard University, Harvard Medical School’s Program in Global Public Policy and Social Change, the National Governors Association, and Partners In Health’s U.S. Public Health Accompaniment Unit hold a session exploring how US state and local public health leaders can implement retrospective contact tracing to identify Covid-19 clusters and mitigate their spread. Currently, almost every US state relies on prospective contact tracing: when an infected person is identified, contact tracers try to identify and notify the infected person’s contacts since being infected. However, there’s an additional, effective method that states can add to their toolkit: retrospective tracing. Once tracers identify an infected person, they can look backwards to find when and where the person was infected and identify who else might have been infected simultaneously as part of a ‘cluster’. Experts are increasingly aware of the outsized effects of superspreader incidents in the transmission of COVID-19 — these are occasions where one or a few persons infect a disproportionate number of other individuals due to a combination of environmental factors, timing, and the activities people are engaged in. As pioneered by Japanese scientists and officials, retrospective tracing identifies those events and allows tracers to discover more cases, more efficiently. Participants Dr. Hitoshi Oshitani, a member of Japan’s Subcommittee on Novel Coronavirus Disease Control whose pioneering work helped develop the retrospective tracing methodology, presents on the retrospective tracing methodology, how it was developed, and how it has been implemented in Japan. Dr. KJ Seung, chief of strategy and policy for Partners in Health’s MA COVID-19 Response, Associate Physician at the Division of Global Health Equity at Brigham and Women's Hospital, and Assistant Professor at the Department of Global Health and Social Medicine at Harvard Medical School presents on how the state of Massachusetts is implementing retrospective tracing methodologies. Professor Zeynep Tufekci, a techno-sociologist at the University of North Carolina who writes publicly on pandemic response for outlets including The Atlantic and is a member of the Berkman Klein Center’s Digital Pandemic Response Working Group, joins Drs. Seung, Oshitani, and Bourdeaux for a question and answer panel focused on implementation of this methodology. Dr. Margaret Bourdeaux, Research Director of the Program in Global Public Policy and Social Change and co-lead of the Berkman Klein Center’s Digital Pandemic Response Policy Practice, introduces and moderates the session.

Dr. Carmen Logie talks about stigma, and how discrimination affects our society. As a Canada Research Chair in Global Health Equity & Social Justice with Marginalized Populations Carmen tells us about her work in refugee camps and how Canadians are privileged to have the basics, like water, for example.Carmen also hosts the podcast called "Everybody Hates Me", where she invites a range of weekly guests to talk about all different kinds of stigma.Support the Show.

In the United States, the pandemic is getting worse than we ever could have imagined. Many of our political leaders underestimated the virus… And as they fumbled the country’s initial response, developing nations with far fewer resources got prepared. This week, we’re looking at Uganda and Rwanda, two countries who have fought pandemics before and were ready for this one. Both countries have lost very few people to the virus. How did they do it?   Guests: Stephen Asiimwe, Program Director, Global Health Collaborative, Uganda Agnes Binagwaho, Vice Chancellor at the University of Global Health Equity, former Minister of Health, Rwanda   If you appreciate this episode and want to support the work we do, please consider making a donation to World Affairs. We cannot do this work without your help. Thank you.

Dr. Carmen Logie is the Canada Research Chair in Global Health Equity and Social Justice with Marginalized Populations at the University of Toronto. Valerie and Carly talk with her about partnering with communities globally on HIV research. Carmen pushes back on research that paints LGBT people as “sad and risky”, advises that we “only get what we ask for” in our work, and grapples with telling stories that document structural oppression while also highlighting individual agency and resilience. Valerie and Carly vow to get fluevogs before their next professional presentations. Read more about Carmen's work here: https://socialwork.utoronto.ca/profiles/carmen-logie/Watch Carmen's Ted Talk here: https://www.youtube.com/watch?v=HOkBN8C-4pcFollow Carmen's podcast here: https://www.buzzsprout.com/1024792

Tired of reading contradictory facts about Covid-19? Same! Thankfully, Harvard Medical School's own, Dr. Abraar Karan, is here to breakdown the scientific facts about the virus. If you are curious about how coronavirus spreads, how long it lasts on surfaces or in the air, why some people asymptomatic, the current treatments being used, and why we are just now being recommended to wear masks- this is a MUST listen. Dr. Abraar Karaan is an internal medicine doctor at the Brigham and Women's Hospital and Harvard Medical Schoo along with his involvement with the Doris and Howard Hiatt Residency in Global Health Equity. He earned his MD from the UCLA David Geffen School of Medicine, an MPH from the Harvard T.H. Chan School of Public Health; a Diploma in Tropical Medicine and Hygiene (DTM&H) from the London School of Hygiene and Tropical Medicine; and his undergraduate degree w/ distinction from Yale. Over the past two years, Dr. Karan has been studying epidemic response as a more specific example of these themes. His previous work over the past 13 years has included projects working on combatting infectious diseases in Latin America (Mexico, Honduras, Nicaragua, Haiti, Dominican Republic), Asia (India, Thailand), and Sub-Saharan Africa (Rwanda, Uganda, Mozambique). His writings and medical journals have been featured in the New England Journal of Medicine, The Lancet, The BMJ, Academic Medicine, Health Affairs, NPR, Vox, Los Angeles Times, Scientific American, Huffpost, the Boston Globe, and other major publications. His book, "Protecting the Health of the Poor", was released in December 2015 and is available on Amazon. Causebox - Visit causebox.com/life for 30% your first Causebox with code LIFE. Produced by Dear Media

Medicine Grand Rounds March 6, 2020 Paul E. Farmer, MD, PhD Kolokotrones University Professor, Harvard University Chair, Department of Global Health and Social Medicine, Harvard Medical School Chief, Division of Global Health Equity, Brigham and Women’s Hospital Co-founder and Chief Strategist, Partners In Health

Dr. Ruma Rajbhandari is an instructor at Harvard Medical School and associate physician in the Division of Global Health Equity at Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R. Rajbhandari and Others. The Neglected Hospital — The District Hospital’s Central Role in Global Health Care Delivery. N Engl J Med 2020;382:397-400.

shutterstock Rwanda has made strides in its health sector in recent years. The country is noted for making faster than expected progress over the past 15 years in reducing deaths among children younger than five. This is the result of the work the government has done in building a strong health system and taking an inclusive approach to health coverage. But there are still challenges like maternal mortality, for example. In today’s episode of Pasha, Agnes Binagwaho, Vice-Chancellor at the University of Global Health Equity in Rwanda, discusses how building trust among the public played a key role in the success of Rwanda’s health sector. Read more: Lessons from Rwanda on how trust can help repair a broken health system Photo: By beast01 – The flag of the country of Rwanda and stethoscope. The concept of medicine. Stethoscope on the flag in the background. Shutterstock Music “Happy African Village” by John Bartmann, found on FreeMusicArchive.org licensed under CC0 1.

In this episode, pioneering physician, anthropologist, and Partners In Health co-founder Dr. Paul Farmer joins Chelsea Clinton to talk about his life’s work to deliver quality, comprehensive health care and fight devastating diseases in some of the poorest places on Earth. Paul has often found himself on the front lines to contain major public health and humanitarian crises in some of the most at-risk places in the world, helping to stop pandemics before they spread and, most importantly, caring for those affected. Together with co-founders Jim Yong Kim and Ophelia Dahl, Paul has forever changed the field of public health through his revolutionary approach to global health equity by supporting strong community-based health systems and partnering with institutions like Harvard Medical School and the Clinton Health Access Initiative to provide all people with world-class medicine. In this episode, Paul shares stories about what he has learned from combating HIV/AIDS, the 2014 Ebola outbreak, and building clinics in countries like Haiti, Rwanda, and Mexico – and why he is optimistic about the future of public health.

Dr. Agnes Binagwaho served as the Rwandan Minister of Health for 5 years, and she is now the Vice Chancellor and co-founder of the University of Global Health Equity. Dr. Binagwaho returned to her home country just two years after the Rwandan Genocide in 1996, and since then has been a leader in fighting for better health systems in the country. In this episode, Dr. Binagwaho shares her thoughts on Rwanda's push for creating better health systems, her ideas on equity in health around the globe, and her perspective on the value of including more women in leadership roles. Learn more about The Bridge podcast and other programs at https://www.aspenglobalinnovators.org/

Emmanuel Kamanzi, Director of Campus Development at the University of Global Health Equity, and Ophelia Dahl ‘94, Founder and Board Chair of Partners In Health, discussed the development of the University of Global Health Equity in Rwanda and its implications on radical changes to health care globally.

The Universal Declaration of Human Rights stipulates that everyone has a right to health. Yet today, 400 million people lack access to essential health services. Thirty years ago, that number was much higher; in recognition of this inequity, Paul Farmer, Jim Yong Kim, Ophelia Dahl, Todd McCormack, and Tom White founded the nonprofit organization Partners In Health to bring high-quality health care to the rural poor in Haiti. The documentary Bending the Arc chronicles the progress and dedication of the organization—which now works in 10 countries around the world—in tackling entrenched diseases, global epidemics, and skepticism among the global community and its institutions. Please join the Chicago Council on Global Affairs and Abbott in hosting Dr. Paul Farmer for a screening of Bending the Arc, followed by a discussion about today's global health challenges, and the importance of public-private partnerships. 

This week on Part 2, Dr. Alex Jadad and I continue the conversation where we left off. We discuss his life work and movement to re-imagine the definition of health not just the absence of disease, but being inclusive of our entire wellbeing, such as love, happiness, and no suffering. If you missed Part 1, I suggest you listen to that episode  (Ep015) first and then come back to this week’s episode. Dr. Alex Jadad, is living his life as a love story. He is also daring us to imagine a world in which everyone could enjoy a life full of love, healthy and happy, until the last breath, as part of a thriving planet. As soon as we meet Alex, we will recognize the curious inner child, the teacher, the learner, the physician and the healer who live in him, urging us to think of ways to make it happen, while marvelling at the wonderful mysteries of life. With Alex, we will learn about possibilities to re-design our lives as love stories, and to bring love to our families, to our workplaces and to our communities, so that we can discover, recover and uncover our capacity to love ourselves and the world, no matter what happens. He will ask us very deep and unusual questions about who we are, questions that will help us to embrace the liberating power of love. Come along. There is no reason to worry. After all, nobody else will ever be able to hear us. All this and more on today’s episode. Now, That’s Unusual.  About Alex Jadad Physician, educator, researcher and public advocate Dr. Alex Jadad is the founder of the Centre for Global eHealth Innovation and Director of the Institute for Global Health Equity and Innovation at the University of Toronto. His research seeks to improve the capacity of humans to imagine, create and promote better approaches to living, healing, working and learning as part of a sustainable planet as he identifies and connects the best minds, best knowledge and best tools across traditional boundaries to eliminate unnecessary suffering. Dr. Jadad has received numerous awards, among them Health Canada’s National Health Research Scholars Award, the New Pioneers Award in Science and Technology and Health Canada’s Distinguished Lecturer Award. He has been featured by Time magazine as one of the Canadians who will shape the country in the 21st century, and as one of the leading medical researchers in Canada. Dr. Jadad is also the author of The Feast of Our Life: Preparing to Flourish Through Self-Love, a text that furthers his mission to enable people to live healthy and happy lives, full of love, until the last breath. Inspired to live his life as a love story, Jadad advocates that we, too, reconnect with ourselves, eradicate regret and embrace the liberating power of love. Key Interview Takeaways “The medical establishment has become a major threat to health.” Jadad cites this Ivan Illich quote to illustrate the shortcomings of the health care system, treating diseases rather than patients. In fact, one million people die every year due to side effects of medications, medical errors and complications resulting from interventions. Health is an ability to adapt and manage the physical, mental and social challenges presented to us. After receiving a probable cancer diagnosis in 2008, Jadad asked himself, “If I have cancer, can I still be healthy?” This led to a global conversation about the concept of health and the reimagining of the definition of what it means to be healthy. Happiness is what happens when what you feel, what you think, what you say and what you do are in alignment. This ‘syzygy’ influences our ability to adapt to challenges we face and thus affects our health and well-being. Health, happiness and love overlap and feed each other, yet these are concepts we rarely study or examine. Jadad suggests that we neglect these themes because they cannot be measured and the ability to quantify something gives us the delusion of control – yet the truly important things cannot be measured. Ideas,

Today, we will meet Dr. Alex Jadad, someone who is living his life as a love story. He is also daring us to imagine a world in which everyone could enjoy a life full of love, healthy and happy, until the last breath, as part of a thriving planet. As soon as we meet Alex, we will recognize the curious inner child, the teacher, the learner, the physician and the healer who live in him, urging us to think of ways to make it happen, while marvelling at the wonderful mysteries of life. With Alex, we will learn about possibilities to re-design our lives as love stories, and to bring love to our families, to our workplaces and to our communities, so that we can discover, recover and uncover our capacity to love ourselves and the world, no matter what happens. He will ask us very deep and unusual questions about who we are, questions that will help us to embrace the liberating power of love. Come along. There is no reason to worry. After all, nobody else will ever be able to hear us. All this and more on today’s episode. Now, That’s Unusual.  About Alex Jadad Physician, educator, researcher and public advocate Dr. Alex Jadad is the founder of the Centre for Global eHealth Innovation and Director of the Institute for Global Health Equity and Innovation at the University of Toronto. His research seeks to improve the capacity of humans to imagine, create and promote better approaches to living, healing, working and learning as part of a sustainable planet as he identifies and connects the best minds, best knowledge and best tools across traditional boundaries to eliminate unnecessary suffering. Dr. Jadad has received numerous awards, among them Health Canada’s National Health Research Scholars Award, the New Pioneers Award in Science and Technology and Health Canada’s Distinguished Lecturer Award. He has been featured by Time magazine as one of the Canadians who will shape the country in the 21st century, and as one of the leading medical researchers in Canada. Dr. Jadad is also the author of The Feast of Our Life: Preparing to Flourish Through Self-Love, a text that furthers his mission to enable people to live healthy and happy lives, full of love, until the last breath. Inspired to live his life as a love story, Jadad advocates that we, too, reconnect with ourselves, eradicate regret and embrace the liberating power of love. Key Interview Takeaways Selfishness and self-love are opposites rather than synonyms. Though Jadad concedes that we often assign self-love a negative connotation, it is impossible to love others if you don’t love yourself. Much like the flight attendant’s instructions to put on your own oxygen mask first and then assist others, we must protect ourselves before we can adequately protect the people we love. The opposite of fear is love. Because we are afraid of what we might find if we engage in serious conversation with ourselves, we choose to avoid dialogue with our inner voice and miss out on the most important relationship of all – the one with ourselves. Of the five fears (death, failure, vulnerability, ridicule and disappointing others), the anxiety of letting people down fuels the idea that there is a gap between what others expect us to be and what we are, creating yet another barrier to self-love. Only by pressing the pause button and connecting with ourselves can we discover, uncover and recover our capacity to love ourselves first. Who would you invite to be a part of your personal board of directors? Nobody can hurt you more than you, so it is important to establish a cadre of people you trust “to love you most when you deserve it least,” protecting you from you and supporting you at your weakest. The path to self-love begins by answering three important questions: What is non-negotiable? What is your verb? What do you regret the most? Once you discover the thing that tickles your soul more than anything else, choose an action connected to that non-negotiable.

Dr. Louise Ivers is an associate physician in the Division of Global Health Equity at Brigham and Women's Hospital and a member of the Special Consulting Group to the Minister of Health and Population of Haiti. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. L.C. Ivers. Eliminating Cholera Transmission in Haiti. N Engl J Med 2017;376:101-3.

Dr. Paul Farmer is sort of the rock god of global health.  He's an incredibly busy and influential guy, so when he flew in from Liberia to spend the entire day here with us at the Carver College of Medicine, it wasn't easy to keep the stars from our eyes.  Of course, he's a physician, but he's also a medical anthropologist, chief of Brigham and Women's Division of Global Health Equity, professor of medicine at Harvard, and the UN Special Adviser to the Secretary-General on Community Based Medicine and Lessons from Haiti.  One of the things you notice about Dr. Farmer is that although he's clearly a celebrity in his field, it doesn't dampen his enthusiasm, idealism, and the pleasure he takes in meeting students who share his passion for understanding and changing how healthcare is delivered to the world's neediest people. What's more, he's the founding director of Partners in Health, an international non-profit that provides direct healthcare services, research, and advocacy to the sick and impoverished around the world in places like Liberia, Haiti, and here in the US.  So, yes, he has things to do. All of which is to say that it's a particular honor that Petra Hahn, Katie Ryken, Josh Bleicher, Jordan Harbaugh Williams, and Greg Yungtum got to chat with him for this week's show to explore the differences between charity, development and liberation medicine; it's Dr. Farmer's emphasis on the latter, and his view that the poor deserve preferential treatment, that makes him such a force in global health. We need validation. Leave a review: iTunes | Stitcher [huge_it_gallery id=”65″] Listen to more great shows for medical students on The Vocalis Podcast Network. The opinions expressed in this feed and podcast are not those of the University of Iowa or the Roy J. and Lucille A. Carver College of Medicine; nor do they reflect the views of anyone other than the people who expressed them.  If you have feedback on anything you hear on the show, positive or not, let us know.…

Last year an epidemic of Ebola erupted in West Africa. The story about the epidemic in the US largely alternated between the fears of the disease coming to these shores and the heroic work of American healthcare workers overseas. Largely missing from the narrative was the perspective of the people from Liberia, Sierra Leone and Guinea and any analysis of the roots of the outbreak in global political and economic policies that have decimated health systems across the region. How does the way we think about equity and justice in health affect health in Africa and across the world and set the stage for epidemic such as the one we've seen emerge over the past year? Participants: Moderator Gregg Gonsalves - Co-director of the Yale Global Health Justice Partnership Chernor Bah - Associate at the Population Council, Co-Founder of A World at School and of the Salone Adolescent Girls Network in Sierra Leone Ashoka Mukpo - Journalist and researcher Adia Benton Assistant Professor of Anthropology, Brown University Francisco Perez - Former Business Development Program Manager, Catholic Relief Services

On October 4th, Dr. Paul Farmer, renowned physician-anthropologist, addressed the Brown University community in a lecture entitled "Rebuilding Haiti." The event was sponsored by Brown's Lecture Board in collaboration with the Office of the Dean of the College. Medical anthropologist and physician Paul Farmer is a founding director of Partners In Health (PIH), an international non-profit organization that provides direct health care services and has undertaken research and advocacy activities, on behalf of those who are sick and living in poverty. He is the Presley Professor of Social Medicine and chair of the Department of Global Health and Social Medicine at Harvard Medical School; chief of the Division of Global Health Equity at Brigham and Women's Hospital; and the United Nations Deputy Special Envoy for Haiti, under Special Envoy Bill Clinton.